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Background 
Prehospital emergency care refers to the management of patients in the out-of-
hospital setting, which is provided by Emergency Medical Services (EMS). Two 
models of such EMS systems exist, namely: the Franco-German and Anglo-Saxon 
Model. The Franco-German model is focused on the on-scene treatment and 
stabilisation of a patient, whereas the Anglo-Saxon model encompasses the scoop-
and-run concept.1 The South African EMS context is built on the combination of 
these models, which provides basic, intermediate and advanced levels of care on-
scene. The basic and intermediate life support practitioners provide more of a 
“scoop-and-run” service, whereas the advanced life support practitioners may 
encompass a “stay-and-play” methodology. The South African state EMS system 
thus provides care to a vast array of prehospital emergencies. In the Western Cape 
context, these emergencies include medical, trauma, inter-facility transfer and rescue 
incidents. This case load represents 46% of medical emergencies, which commonly 
includes the management of acute-symptomatic hypoglycaemia.  
Acute symptomatic hypoglycaemia (SH) refers to the decrease in blood glucose 
levels with concomitant decreased level of consciousness and subsequent 
sympathetic responses or seizues.2 Currently, various cut-off values for defining 
acute SH exist in the literature. These values have a range of 3.0mmol/l – 
3.5mmol/l.33 In the South African prehospital context, it is defined as a blood glucose 
level of less than 3.5mmol/l with the presentation of an altered level of 
consciousness.3 Other manifestations include cardiovascular disturbances (such as 
myocardial infarctions and arrhythmias) and neurological abnormalities (such as 
transient ischemic attacks and cerebrovascular accidents).2 SH may also lead to 
death if left untreated.2  
In the South African prehospital context, acute SH is classified as priority one call 
out, where response to such cases should be achieved in less than 15 minutes. 
Hence various governmental and non-governmental EMS agencies may respond to 
these callouts when they occur.  
The primary underlying causes of SH are Type I and II diabetes mellitus.  In a 2011 
review, it was described that in Africa, Type I diabetes mellitus  is poorly 
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characterised in terms of its aetiology and epidemiology, however did describe a 
lower prevalence thereof.6 In a 2008 cross-sectional survey of Type II diabetes 
mellitus in Bellville, Cape Town, the prevalence of Type II diabetes mellitus was 
28.2% compared to a global trend of 3.5%.4, 7 SH may be induced by underlying 
pathologies, medications or toxins, but is usually a direct result of the injectable 
insulin alone or concomitantly with oral diabetic treatment agents in Type 1 or II 
diabetes mellitus.2   
It has been common practice for an EMS crew to leave a patient at home post 
reversal of acute SH. This decision is based upon patient autonomy post-return of 
vital signs to within normal parameters, which specifically includes level of 
consciousness and blood glucose levels > 3.5 mmol/l.3 Discharge of these patients 
may also be based upon the patients’ wishes to receive further treatment and/or 
transport. Patients may also refuse further care based on external factors related to 
personal preferences and socioeconomic conditions. Current protocols as set out by 
the Health Professions Council of South Africa which governs prehospital emergency 
care, providers enforce that patients who have experienced an emergency event 
should be managed and transported to hospital by EMS.3 However, a patient has the 
right to refuse transport and treatment.3 In addition, these protocols are open to 
interpretation and therefore adherence is variable. These protocols are supposed to 
be updated every 5-years, but in actual fact have not been since 2006.3 In terms of 
the management of acute-SH in the prehospital environment, it does not specifically 
address management factors, in particular the aspect of discharge post-SH reversal. 
This protocol only describes oral glucose, intravenous dextrose and glucagon as the 
agents to be administered.  Furthermore, the Western Cape EMS clinical standard 
operating procedures does not provide any guidelines on the management and 
disposition of acute SH patients in the prehospital environment. 
These factors may lead to the  premature discharge of acute SH patients and 
consequently  may result in recurrent episodes.2 The criteria for leaving symptomatic 
hypoglycemic patients at home and the appropriateness of the procedure remain 
controversial; and often crucial associated underlying causes and complications are 
missed, with repeat episodes of SH potentially risking further morbidity and 
mortality.9 Another consideration in this discussion would be the additional burden 
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placed on an already stretched EMS system. Anecdotally, unnecessary and 
predictable repeat calls for SH episodes would simply add to this. By leaving these 
patients at home the causative factors are not determined and managed.  
Without knowing the actual effect prehospital discharge of treated acute SH patients 
has, short- and long-term on patient care and outcomes such as underlying 
pathologies triggering the SH episode may not investigated and patients run the risk 
of recurrent episodes.9 In a recent review evaluating complications of acute SH at a 
Hospital in Johannesburg, South Africa, it was shown that in almost three-quarters of 
these patients, the  precipitating causes included gastrointestinal abnormalities 
(20%) and inappropriate treatment (51%).5  
The role of prehospital emergency care practitioners with extended skills over and 
above those foreseen by the current protocols is evolving, enabling them to assess 
and treat patients in the community. These new models of care, including further 
assessment, triage, and treatment skills for prehospital care providers, have been 
recommended to help manage ever increasing demands for healthcare. Current 
evidence concerning safety, effectiveness, and costs to support these changes in 
practice is lacking.  
1. Objectives of Literature Review 
The primary objectives of this literature search were to determine: 
• the number of patients experiencing their first ever episode of SH  
• the short-term outcomes of patients experiencing their first episode of acute 
SH, and  
• re-activation rates of EMS after the index episode, post reversal and 
discharge.  
Secondary objectives included the following: 
• determination of hospital admission rates, and  
• the provision of follow-up care instructions provided by prehospital care 
providers prior to discharge.  
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These objectives were aimed at the prehospital care strategies in various EMS 
environments to provide a benchmark against which current practice in the Western 
Cape EMS context could be evaluated.  
2. Methodology 
2.1 Search Strategy 
The following search strategy utilising MeSH terms and keywords as 
outlined below was used across two medical databases, namely EBSCO 
Host, Cochrane and Medline: 
(prehospital OR out-of-hospital [Title/Abstract] OR paramedic 
[Title/Abstract] OR ambulance [Title/Abstract]) AND (treatment 
[Title/Abstract] OR management [Title/Abstract]) AND (symptomatic 
[Title/Abstract]) AND (hypoclycemia [Title/Abstract]) AND (discharge 
[Title/Abstract] OR treat-and release [Title/Abstract] OR see-and-treat 
[Title/Abstract] OR outcomes [Title/Abstract] OR follow-up [Title/Abstract]) 
OR disposition [Title/Abstract]). 
The following search limiters were applied during the search: 
• Language:  English only 
• Articles:   Linked full text,abstracts and all other article 
sources 
• Publication Date: 1998 – 2013 
• Publication Type: All 
• Population Type: Human 
• Age Groups:  Adults 19+ 
• Gender:   Male and female 
• Geography:  Open 
2.2 Inclusion & Exclusion Criteria 
Apart from the search limiters outlined above, the following parameters 
were also applied: The review includes all electronically indexed eligible 
articles up to and including 31st October 2013.   
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Inclusion Criteria: 
• Publication Types: Primary and secondary sources,  
conceptual, anecdotal and clinical opinion 
• Population:  Male and female patients older than 19  
years 
• Publication years: 1998 – 2013 
• Primary Outcomes: Short-term effects of prehospital discharge  
post hypoglycemic event reversal 
• Secondary Outcomes: Emergency Centre management and  
outcomes of hypoglycemic patients post 
discharge in cases of diabetes mellitus 
Exclusion Criteria: 
• Population:  Non-humans 
• Language:  Non-English publications 
• Setting:   Interventions not carried out in the primary  
or in-patient setting 
• Outcomes:  Primary and secondary outcomes that does  
not report the short-term effects 
hypoglycemic management 
2.3 Quality Criteria 
For each search string used, the resulting titles of the articles and 
abstracts were analyzed in alignment to the objectives of this review (see 
below).  If the title and/ or abstract met the inclusion and exclusion 
criteria, the full articles were retrieved and read in their entirety. The 
references at the end of these articles were also reviewed to identify any 
missed articles.  Lastly, the references of this final collection were also 
examined to identify any additional articles potentially missed during the 
initial search.   
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2.4 Search & Screening Results 
The search strategy was adjusted within EBSCO Host, Cochrane and 
Medline and yielded 3833 articles. Advanced limiters were applied using 
the following key fields: prehospital, out of hospital, Emergency Medical 
Services (EMS), Emergency Medical Technician (EMT) and Paramedic; 
and yielded 767 potential articles. Based on the search strategy in 
correlation with the article titles and repeat hits, 35 were eliminated. A 
total of 41 articles were screened and 7 were omitted based on the 
abstract meeting the criteria. A remainder of 34 full-text articles was 
reviewed and 10 excluded based on the inclusion and exclusion criteria. 
In conclusion, 22 articles were included for the literature in alignment to 
the objectives. The following flow diagram (Figure. 1) summarizes the 
article search and screening process: 
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Figure 1 
 
 
3. Literature Review 
Based on the above, Table 1 outlines the sources of literature, the design, key 
findings and limitations of the 22 included articles, laid out in order of 
increasing level of evidence and oldest to youngest year of publication:  
Potential relevant research articles 
as identified in the literature 
search strategy:  
76 
Articles rejected based on title:  
14 
Total screened articles: 
41 
Articles rejected based on 
abstract:  
7 
Total full-text reviews: 
34 
Full-text articles rejected based on 
inclusion-exclusion criteria:  
12 
Total number of articles 
included in this review: 
22 
Articles rejected based on repeat 
hits:  
21 
Unfiltered potential relevant 
research articles as identified in 
the literature search strategy:  
3833 
Limiters applied 
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Table 1:   Study Designs and key findings of included papers by year of publication 
Reference 
Number 
Author, Date 
& Setting 
Study 
Design 
Key Findings Limitations 
26 Capes et al, 
2001 
 
Systematic 
Review 
In 26 articles, the relative risk for mortality and 
stroke post hyperglycaemia was calculated. 
Patients with hyperglycaemia were shown to be 
at risk of mortality or stroke. 
Heterogeneity 
 
8 Roberts et al, 
2003 
 
Systematic 
Review 
Showed that out-of-hospital treatment protocols 
for hypoglycaemic patients were safe in 90% of 
patients. 
Based on out-dated 
Literature (1990-1999) 
14 Donelly et al, 
2005 
Systematic 
Review 
In 267 patients treated with insulin, 45% had 
subsequent episodes of hypoglycaemia. 
Variations in study 
designs, heterogeneity 
and inconsistent 
definitions of 
hypoglycaemia across 
studies 
27 Nehme et al, 
2009 
Systematic 
Review 
In 3651 potential articles, 24 articles that matched 
the inclusion criteria showed that 10% dextrose 
yielded and equal time to normal level of 
consciousness as compared to 50% dextrose. 
Search limited to 
English articles only 
No hand-search for 
articles were 
conducted 
20 Fitzpatrick et al 
2009 
UK EMS 
 
Systematic 
Review 
This review of 23 papers showed an incidence 
from 0.8% - 23% oral hypoglycaemia inducing 
agents. Incidents of repeat callout for SH events 
were between 2-7%.   
Only English papers 
were retrieved. Little 
high quality papers 
were found. 
24 Frias et al, 
2010 
 
Systematic 
Review 
82 Cases of adverse events found in literature 
related to false glucose readings using GDH-
PQQ test strips 
Voluntary reporting. 
Small sample size 
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29 Gerstein et al, 
2008 
Hospital 
Randomised 
Controlled 
Trial 
In terms of standard therapy vs. intensive glucose 
lowering agents in type 2 diabetes-  
Primary Outcome: Occurrence of non-fatal MI, 
stroke or death – Hazard Ratio 0.90 (0.78 – 1.04) 
95% CI 
Secondary Outcome: Death from any cause – 
Hazard Ratio 1.22 (1.01 – 1.46) 95% CI 
Non-standardised 
dosing strategies. 
10 Frye et al, 
2009 
Multicenter 
Cardiac ICU 
patients 
Randomised 
controlled trial 
Of 2368 cardiac re-vascularization cases, 88.3% 
of were provided insulin. Of these 9.2% 
developed multiple episodes of hypoglycaemia. 
Hypoglycaemia was 
not the primary or 
secondary end-points 
of this study 
21 Steinmetz et al, 
2006 
Prehospital 
and in hospital  
 
Prospective 
cohort  
Of 139 participants, 6 patients were left at home 
and required hospital admission through EMS 
within 48 hours. 
Small sample size, 
patients managed in 
the prehospital context 
were managed by 
physicians 
22 Brackenbridge 
et al, 2006 
District 
Emergency 
Departments & 
EMS, United 
Kingdom 
 
Prospective 
Cohort 
In 111 prehospital cases with diabetes, 51% of 
patients presented with a blood glucose of less 
than 4mmol/l. Of these, only 27% were 
transferred to hospital. 
In the hospital context, 251 cases presented to 
the units over 12-months with diabetes. 94 
Patients presented with hypoglycaemia, which 
presented with the following underlying 
pathologies: UTI’s (n=6), low GCS (n=4), head 
injury (n=3), chest infections (n=3), diarrhoea 
Hypoglycaemia as a 
measurable not clearly 
defined. 
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and/or vomiting (n=2). 
18 Strote et al, 
2007 
EMS context, 
USA 
Prospective 
cohort 
203 cases were surveyed out of 402 prehospital 
hypoglycaemic cases. There was a 16% repeat 
episode rate of SH, 14% reactivated EMS within 
48 hours and 11% required hospitalisation. 
Inconsistent study 
population, large 
portion of the study 
populations couldn’t 
be contacted.  
23 Voulgari et al, 
2011 
Hospitalised 
Patients 
Method 
Comparison 
Three brands of glucose monitors were evaluated 
and compared to standard lab measurement. All 
three-blood glucose monitors under-sensed 
levels of blood glucose when compared to 
laboratory measurement. 
After calibration of 
monitors no quality 
control measures were 
applied on a daily 
basis to ensure 
accuracy amongst 
monitors.  
Wide confidence 
intervals 
2 Mechem et al, 
1998 
Philadelphia 
EMS, USA 
Prospective 
descriptive 
study 
132 Patients enrolled, 103 patients were 
contacted by telephone, 94 patients had no 
recurrent SH episodes, nine had recurrent 
episodes and 8 of these patients were 
transported to hospital.  
Inconsistent telephonic 
interviews and 22% of 
the sample population 
was missed for 
telephonic interviews.  
13 Carter et al, 
2002 
 
Prospective 
descriptive 
study 
A total of 157 patients were included in the study, 
however only 60 were contactable, who refused 
transport post SH reversal. There was a 31.58% 
repeat need for healthcare in the transported 
group compared to 14.63% in the refusal group. 
Selection bias due to 
only 60% of eligible 
patients being 
contactable 
9 Desouza et al, 
2003 
Prospective 
descriptive 
In 54 patients presenting with hypoglycaemia, 
cardiac chest pain symptoms were associated 
Continuous glucose 
monitoring systems 
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USA study with 10 of these cases. In 4 of these 10 cases, 
ECG abnormalities were detected 
may have been 
inaccurate as it 
measured interstitial 
fluid, compared to 
blood glucose. 
15 Henderson et 
al, 2003 
 
Retrospective 
survey 
In 215 patients treated with insulin, 73% 
presented with hypoglycaemia. 
Heterogeneity in study 
population 
16 Holstein et al,  
2003 
EMS Germany 
Prospective, 
population 
based survey 
In 7804 prehospital cases, 215 cases were found 
to present with SH. Of these 50 patients 
presented with sulfonylurea induced SH 
1173 Cases were 
excluded due to 
ethical and inclusions 
reasons. Cases 
representative of a 
single EMS district  
17 Leese et al, 
2003 
Ems Academic 
Hospital, 
United 
Kingdom 
Retrospective 
cross-
sectional 
survey 
In 8655 cases of diabetes, 160 cases presented 
with 244 episodes of hypoglycaemia over a 12-
month period. 
Cases of 
hypoglycaemia treated 
outside the EMS or 
hospital environment 
were excluded. 
28 Cain et al, 
2003 
EMS 
Prospective 
Observational 
Study 
In 220 calls for adult patients with hypoglycaemia, 
75 resulted in transport, there were 17 further 
hypoglycaemic episodes requiring a repeat calls 
for EMS (22.7%) and three recurrent episodes 
(4%). Of the 145 calls that did not accept 
transport, 40 recurrent episodes of 
hypoglycaemia (27.6%) were reported. 
Inability to measure 
medication 
involvement in 
outcomes 
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12 Raghavan et 
al, 2007. 
Clinical 
Review 
Antibiotics ( Bactrim, Cephalosporins and 
Penicillin) known to induce hypoglycaemia 
Clinical review, no 
formal evidence 
provided 
25 Ginsberg et al, 
2009 
 
Review Key glucose strip inaccuracies include strip, 
physical, patient, and pharmacological factors. 
 
 
11 Sharma et al, 
2009 
Clinical 
Review 
Hypoglycaemia yet uncommon, found in patients 
with diabetes on beta-blockers. 
Clinical review, no 
formal evidence 
provided 
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Discussion 
The management of acute SH includes patient assessment and the 
administration of anti-hypoglycaemic agents with the aim of returning blood 
glucose levels to normoglyceamia. Prehospital and in-hospital protocols for 
acute SH include the treat-and release of patients post-SH reversal. However, 
the literature showed that the factors and effects, which should be considered, 
include: 
1. Patient autonomy for refusal of transport post-SH reversal 
2. Prehospital capabilities to determine underlying SH causative 
pathologies 
3. Medication induced acute SH 
4. Increased risks for repeat SH episodes post discharge and repeat EMS 
callouts 
5. Hospital admission post-discharge 
6. Follow-up care strategies post-discharge 
7. Tools and drugs for prehospital SH management 
8. Drug availability in the context of prehospital treatment of acute SH 
 
3.1 Patient autonomy for refusal of transport post SH reversal 
Post-acute SH reversal, the patient may elect to seek further medical 
care which includes hospital admission or may refuse further care. 
Patient autonomy and legal right to refuse further care need to be 
taken into consideration if the patient is mentally able to make such a 
decision. This mental ability is a subjective compound assessment 
based on both Glasgow coma scale and background mental age, as 
well as any comorbidities.This may ultimately be in conflict with the 
patient’s welfare. However, decision making ability may be impaired 
immediately following an episode of SH.2 One of the hallmarks of 
severe SH includes an altered level of consciousness, with possible 
resultant confusion, which may hamper decision making, decrease the 
ability to reason and present with short-term memory loss.1 This may 
constitute a danger to the patient and bystanders. These bystanders 
Part A – Literature Review 
 
may constitute family members or the public in close proximity to the 
patient. The lack of reasoning capability may thus result in harmful 
abnormal behavioural patterns.2 In a recent psychology review, it was 
shown that hypoglycaemia may result in aggression, criminality, 
violence and the ability to inflict self-harm.31 However, this review was 
specific in hypoglycemic patients and not applied within the context of 
other underlying causative pathologies, linked to the prehospital 
context.  An emerging factor was that of treat and release protocols in 
with respect to prehospital acute-SH patients. However, no published 
clinical trials were found with specific measurement against the 
prehospital discharge of acute SH post reversal and the outcomes 
thereof in specific relation to these protocols. Acute SH is often 
underestimated by patients’ post-reversal. They often may not consider 
it to be a serious side-effect to diabetes mellitus or representative of 
underlying pathologies.8 Thus they may be misinformed in terms of 
their presenting condition and this may result in negative patient 
outcomes. 
3.2 Prehospital capabilities to determine underlying SH causative 
pathologies 
SH may be disease-, medication-, or toxin induced. The determination 
of the underlying cause plays a key role in the effective management 
and secondary prevention of SH and the associated negative 
outcomes. In a recent review it was found that there was a close 
association between Type 2 DM and concomitant hypertension, 
dyslipidaemia and underlying cardiac pathologies and dysrhythmias.9 
The development of acute SH and recurrent episodes thereof may be 
indicative of the worsening of these comorbidities. A study based on 
continuous electrocardiogram (ECG) and glucose monitoring during SH 
reversal showed that 10 out of 54 SH cases showed ECG changes.9 
This may particularly predispose SH patient with underlying cardiac 
pathologies to dysrhythmias. However, in the Bypass Angioplasty 
Revascularization Investigation 2 Diabetes (Bari 2D) trial it was shown 
that severe hypoglycaemia was 9.2% more frequent in patients with 
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underlying cardiac pathologies whilst on insulin therapy for diabetes 
treatment.9  
The 2008 ACCORD trial evaluating 10 251 patients with underlying 
cardiovascular risk and glycaemic control, showed a 35% increase in 
mortality due to a cardiovascular event.29 Cardiac medications such as 
beta-blockers and salicylates has also been shown to predispose 
cardiac patients to incidents of acute SH, if the patients had underlying 
Type 2 diabetes mellitus. However no evidence was found of acute SH 
episodes directly causing such cardiac events.10 It was also further 
found that acute-SH may mimic transient ischemic attacks, ischemic 
strokes, arrhythmias and  myocardial infarctions.12 However no articles 
were found in relation to the long-term outcomes of these presentations 
and its diagnosis from acute-SH patients managed and discharged in 
the prehospital context.  
Predisposition to acute-SH may also be associated with multiple drug 
interactions in the treatment of chronic underlying conditions.  
A review analysing key aspects of symptomatic hypoglycaemia also 
showed various diseases which may induce hypoglycaemia (Table 2), 
however little evidence was found linking these disease causation to 
acute SH in the prehospital context post reversal.12  
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Table 2: Disease-Induced Symptomatic Hypoglycaemia 
1 Type I Diabetes Mellitus 
2 Type II Diabetes Mellitus – Also associated with hypertension and 
dyslipidaemia 
3 Renal disease 
4 Adrenal insufficiency 
5 Local & systemic infections 
6 Islet cell adenoma 
7 Liver cirrhosis 
8 Idiopathic hypoglycaemia 
9 Autoimmune compromise 
10 Pregnancy induced hypoglycaemia 
11 Renal glycosuria 
12 Hormonal insufficiencies 
 
Adrenal insufficiency can cause hypoglycaemia due to the lack in 
adrenal hormone secretion such as adrenalin, noradrenalin or cortisol, 
which plays a vital role in regulating sugar levels.12 Carcinomas and 
insulinomas may induce hypoglycaemia, due to the secreted insulin 
being hampered by tumour cells. Thus insulin secretion is not 
controlled by glucose and may results in lower than normal blood 
glucose levels.12 Liver cirrhosis results in the interference of the 
structural, intracellular and chemical makeup of the liver. Any change 
of these components results in inadequate glucose level controls by 
limiting the ability of gluconeogenesis by the liver.12 Pregnancy-induced 
hypoglycaemia may also occur as a result of the increased hormone 
levels which regulates insulin secretion.12  
In terms of the above disease-induced causes of hypoglycaemia, no 
evidence was found internationally and locally evaluating the 
prevalence and effects of prehospital discharge of acute-SH patients.  
In a 2002 retrospective cross-sectional survey in which assessed 
patient satisfaction post SH reversal in 100 cases in the prehospital 
setting. In this survey, in which 60 participants were contactable, a 
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repeat callout rate 14,63% was found. Within this latter group, three 
patients were diagnosed with chest infection, myocardial infarction and 
a foot infection respectively.13 These diagnoses thus suggest a need 
for further clinical investigations to rule out underlying causes and 
pathologies which may be represented by an acute SH episode. 
In the Western Cape EMS context, there is very little scope for the 
detection and management of these diseases in the pre-hospital 
environment. The protraction of these diseases may lead to an 
increase in morbidity and mortality. Furthermore, it may also result in 
an increase in healthcare demand in an already resource confined 
setting. 
3.3 Medication induced acute SH 
The following medication related factors were found in the literature in 
terms of acute-SH: 
1. Concomitant medication usage 
2. Insulin dosage 
3. Sulfonylurea adverse effects 
4. Antibiotic effects 
Acute SH can also be induced by medication use (including 
hyperglycaemic agents) alone or in combination with multiple 
medication dosages. Elderly patients may specifically be predisposed 
to acute SH by multiple drug interactions due to increased tissue 
sensitivity to concomitant medication usage. In a 2009 case review 
evaluating drug interactions and renal disease, it was described that 
renal disease often results in adverse drug reactions and as a result 
increases the risk of acute SH.11 The decreased glomerular filtration 
rate and subsequent creatinine clearance impairs the elimination of 
multiple renal cleared medications   
In the South African prehospital context, callouts are often received for 
patients on multiple medications due to a number of chronic diseases. 
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In relation to this, the EMS curriculum for practitioners does not include 
the interpretation application of these medications.3 No evidence was 
found evaluating the presentation of these patients on concomitant 
medications, acute-SH and outcomes post discharge in the South 
African prehospital context. 
Type I diabetes mellitus is primarily managed through the 
administration of rapid, short or long acting insulin.31 In cases of Type II 
diabetes mellitus insulin (rapid, short or long acting), sulfonylureas 
and/or metformin may be administered.31 A prospective study 
evaluating the treatment of Type 1 and Type 2 DM in 267 patients 
showed that 45% of the cases were treated with insulin and had a 
single or multiple episode/s of SH over a period of time.14 However, the 
study duration was short and was unable to ascertain how many 
dosage adjustments were made in relation to subsequent SH episodes. 
In another retrospective cross sectional study evaluating the treatment 
of 215 Type 2 diabetes mellitus patients, it was found that 64% had a 
subsequent acute SH event, of which 15% were classified as “severe”, 
defined as a blood glucose level less than 2.5mmol/l and an altered 
level of consciousness.15  
Both these studies concluded that post the index SH episode, insulin 
dosage adjustments had to be made to mitigate subsequent episodes, 
with hospital admission and monitoring required. These insulin 
adjustments required close monitoring in relation to blood glucose 
levels and fasting glucose laboratory investigations. However these 
studies lacked in providing the adequate timeframe for admission and 
monitoring required.  
A prospective cohort study evaluating the care of prehospital 
hypoglycaemia found that 4.9% of 213 SH cases were as a result of 
sulfonylurea use16, an agent widely used in Cape Town. Another 
population based dataset analysis investigating 160 cases showed that 
SH episodes were induced by sulfonylurea and metformin 
administration in 23 and 69 of cases respectively.17 These study 
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outcomes were similar when comparing the results of agents used and 
the number of acute-SH episodes. It was thus evident that 
hypoglycaemic agents play a major role in causing SH, especially if 
injectable insulin is used.  
Antibiotics used for the treatment of infections may often cause 
symptomatic hypoglycaemia by increasing insulin secretion.12 This may 
be potentiated in patients with type 2 diabetes mellitus on sulfonylurea 
treatment. It was also further described that ethanol can precipitate a 
SH response, as it results in decreased endogenous glucose 
production and glycogenolysis. Ethanol abuse may particularly be of 
concern in patients from poor socio-economic status, with resulted 
malnutrition, decreased endogenous glycogen and glucose stores and 
resultant recurrent acute SH episodes. 
In chronically-ill patients on broad medication usage, dosage and 
administration adjustments may need to be considered to prevent 
adverse medication events, such as medication induced 
hypoglycaemia. These adjustments are dependent on continuous 
clinical and laboratory investigations which cannot be administered in 
the prehospital context.  
3.4 Increased risk for repeat SH episodes post discharge and repeat EMS 
callouts 
Repeat episodes post SH reversal and prehospital discharge was an 
emerging theme throughout the screened literature. A follow-up survey 
comparing outcomes of 203 paramedic treated SH patients in the 
prehospital setting, showed that 9% (n=19) of cases experienced a 
repeat SH episode.15 In another prospective short-term outcome based 
survey of 103 insulin-dependent SH patients who refused transport 
after dextrose administration, 91% (n=94) had no recurrent SH 
episode.2 However both these studies did not mention the time period 
within which the repeat SH episode occurred relative to the index 
episode.  
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In contradistinction, another prospective cohort study evaluating the 
outcomes of 220 SH patients treated and not transported in the 
prehospital context, it was found that of the 34% (n=75) patients who 
were transported, 22.7% (n=17) had recurrent SH episodes in 24 
hours, and 4% (n=3) within 48 hours.28 However these episodes were 
not evaluated against special investigations and resultant clinical 
cause. 
As a result of repeat episodes, a fair percentage of acute SH patients 
will require repeat access to healthcare, usually via the EMS system. In 
a telephonic survey evaluating patient satisfaction post discharge 
amongst 41 candidates, it was found that 14.6% (n=6) required repeat 
access to healthcare for general complaints and 4.8% (n=2) for a 
recurrent SH episode.13 In another follow-up survey evaluating 
prehospital emergency care providers’ treatment of hypoglycaemia, it 
was found that of the 199 cases, 11% (n=8) reactivated EMS through 
the call centre.18 These studies took place in the urban USA 
prehospital context – a context with vast differences as compared to 
the Western Cape population. These studies did not describe the 
population-mix and timeframe within which EMS was activated and the 
specific short and long-term outcomes thereof. These repeat EMS 
callouts may have significant cost implications for EMS systems and 
may affect the availability of resources.19, 20  
All of the studies listed above were conducted outside of Africa. No 
local studies were found that investigated the issue here. 
Inconsequently there has also been no local health economic 
evaluation of this particular type of presentation, practice, repeat 
episode and discharge. 
3.5 Hospital admission post discharge 
In a 2006 prospective cohort study assessing 139 prehospital SH 
patients’, it was found that 6% (n=8) required hospital admission post 
prehospital discharge.21 However, this study did not identify the 
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underlying causative factors for hospital admission. In another follow-
up survey of 199 discharged SH patients post reversal within the 
prehospital context, it was found that 16% (n=17) required hospital 
admission.18 In this study it was also noted that severe cases of 
hypoglycaemia were shown to have an 18% recurrence rate within 48 
hours. This study showed a link between prehospital discharges of 
acute SH patients and the requirement for hospital admission in the 
context of Type II diabetes mellitus   
3.6 Follow-up instructions and patient information post discharge 
Within the literature search, two criteria for safe discharge emerged 
which included follow-up instructions and patient information. These 
were defined together as the provision of effective information in terms 
of patient education and advice to prevent and management 
subsequent SH episodes. The key findings included: 
1. Educating patients prior discharge reduced SH recurrence 
2. In certain cases, the presenting condition may affect decision 
making capabilities and thus hamper the receipt of information 
provided 
3. Patient education should include medication administration 
methods 
4. Content of follow-up and patient information 
 
Acute SH is related to secondary brain dysfunction. It has been shown 
that frequent recurrent episodes of acute SH may result in decreased 
brain function.18 This may affect a patient’s ability to understand follow-
up instructions and make coherent decisions on further treatment and 
transport to hospital for further diagnostic investigations. In one follow-
up survey of 203 discharged SH patients, it was found that in 48% 
(n=97) received follow-up instructions; however no description of the 
follow-up content and procedures were provided in this study.18 This 
study also showed no link between the provision of these instructions 
and the outcomes thereof. No further evidence relating to the provision 
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of follow-up instructions was found. In a 2006 prospective cohort study 
evaluating the use of emergency services by diabetic patients, it was 
described that patient education with reference to diet and blood 
glucose control with diabetic agents was lacking.21 It was further 
described in this study that the required education in diabetic care was 
not standard for prehospital care providers, which may have been 
linked to their scope of practice.21 Furthermore no evidence was found 
on the methodology and how to overcome communication barriers with 
which follow-up strategies should be provided to patients post SH 
reversal. This is of particular concern in South Africa considering the 
cultural diversity. 
3.7 Tools for Prehospital SH Management 
The capability of measuring an accurate blood glucose level must exist. 
In a 2011 method-comparison study, comparing blood glucose 
measurements of three brands of blood glucose monitors to that of 
clinical laboratory analysis within a hospital setting found that these 
monitors performed poorly at extreme blood glucose values, i.e. 
resulted in an underestimation of hypoglycaemia and an overestimation 
of hyperglycaemia.23 In another review evaluating adverse events 
associated with false glucose readings, it was described that the 
following factors affect the accuracy of blood glucose readings:24, 25 
1. Blood glucose strip accuracy  
2. Physical factors (altitude and temperature),  
3. Underlying patient constraints (glucometer usage) 
4. Concomitant drug therapies  
 
Strip accuracy is affected by strip-to-strip variation, enzyme reactivity, 
sufficient sample and expiry date. Physical factors include altitude and 
temperature as biochemical and blood reactivity varies under these 
extremes. Patient constraints such as incorrect machine coding, 
inadequate technique and hand washing may affect readings. 
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Concomitant drug therapies may also cause cross reactivity and 
hamper blood glucose level readings.24, 25  
No studies were found with reference to environmental factors affecting 
the accuracy of blood glucose readings within the prehospital context, 
thus leading to speculation of its effects. Equipment in the South 
African prehospital environment in general and Cape Town in 
particular, is exposed to extremes in temperature and humidity ,which 
one can speculate may result incorrect blood glucose levels with test 
strip and glucose monitors.  
3.8 Drug availability in the context of prehospital treatment of acute SH 
In the South African prehospital context, the following agents are 
available to treat SH: 
1. Oral glucose 
2. Intravenous dextrose  
3. Glucagon (intramuscular and intravenous) 
 
Intravenous dextrose is a hypertonic solution which increases blood 
glucose levels in hypoglycaemia and is a source of carbohydrates. Its 
major function is to prevent the depletion of glycogen stores in the liver, 
and thus plays a vital role in metabolism. Current protocols suggest the 
administration of a 50% intravenous dextrose infusion in SH patients.3 
However, a recent review evaluating the efficacy of 10% versus high-
concentration intravenous glucose in the out-of-hospital context, it was 
concluded that 10% intravenous dextrose yielded the same response 
time to normoglycemia as compared to 50% dextrose.27 It was also 
shown that high concentrations of glucose did not match the rate of 
whole body uptake and may result in recurrent SH episodes. However, 
this study did not evaluate the correlation to prehospital discharge of 
SH patient post 50% intravenous dextrose administration and the 
short- and long-term outcomes thereof.  
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Current protocols for South African prehospital care providers also 
includes the administration of oral anti-hypoglycaemic agents in cases 
where intravenous access cannot be established, or where care is 
provided by basic life support practitioners. In a recent systematic 
review, it was concluded that the reversal of SH using oral agents was 
short acting and often resulted in recurrent SH episodes.27 However, a 
major limitation to this review was the determination of timeframes with 
reference to recurrent SH episodes post administration of oral agents 
and recovery within the prehospital context. 
Glucagon is counter-regulatory hormone acting against insulin and the 
effects thereof. In a 2011 review evaluating the efficacy of glucagon 
administration, it was described that glucagon should be the first line of 
therapy in cases of acute-SH.32 After intramuscular or intravenous 
administration, it rapidly mobilises endogenous glycogen and glucose 
stores. However, one of the disadvantages is that it has a short half-life 
and is only available to ALS providers. Thus the majority of 
practitioners in the Western Cape do not have access to glucagon for 
the management of acute-SH. 
 
Summary of Main Findings 
In patients presenting with Acute SH in the prehospital environment, refusal of 
further treatment and transport to hospital post SH reversal may occur. However, 
decision making ability in these patients may be hampered by underlying pathologies 
or the acute effect of the SH. The capabilities and scope of EMS personnel to detect 
these underlying pathologies are limited. Various medications and pathologies may 
induce symptomatic hypoglycaemia, and if not correctly managed may result in 
recurrent episodes. This may be further exacerbated by the type of SH reversal that 
was applied by the EMS responder. These episodes may result in subsequent EMS 
callouts and protracted hospital admission rates. Repeat episodes may also increase 
the risk to these patients in terms of an increased mortality and morbidity. In cases 
where EMS has discharged these patients, follow-up instructions with reference to 
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further care in the mitigation of recurrent episodes prior discharge, were found to be 
inadequate. 
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ABSTRACT 
 
Background: There has been a growing prevalence of patients with chronic medical 
conditions in South Africa, diabetes mellitus being one of them. Acute symptomatic 
hypoglycaemia (SH) refers to decreased level of plasma glucose <3.5mmol/l accompanied 
by an altered level of consciousness. Prehospital management of such episodes includes 
reversal by oral and/ or intravenous glucose administration, or intramuscular glucagon 
administration. Post-reversal, patients may refuse transport to hospital, which may result in 
recurrent episodes of acute SH. 
Methods: A retrospective cross-sectional study design was used. Patient report forms 
from patients with SH managed prehospitally between May 2012 and September 2012 in 
the greater Cape Town area were extracted from the Emergency Medical Services (EMS) 
database. A follow-up survey using a closed-ended questionnaire was administered to 
these same patients within 7 days post-reversal to evaluate the efficacy of prehospital 
discharge of SH patients.  
Results: A total of 110 eligible patients were identified and telephonically interviewed. It 
was found that 21(19%) of cases had subsequently died. Of the 89 remaining cases, 30 
(34%) reactivated EMS within 7 days of discharge, independent of SH being the chief 
complaint. In total, 48 (54%) had recurrent episodes of SH within 7 days of discharge by 
EMS. In 47 (53%) of cases discharged by EMS, no follow-up instructions were provided to 
mitigate recurrent SH episodes or complications.  
Conclusion: More than half of patients who received pre-hospital treatment and discharge 
for SH have recurrent symptoms post reversal by EMS staff, with a third needing to recall 
the EMS. This would suggest that the current strategy of dealing with such cases needs 
careful re-evaluation to improve the quality management of this patient population.  
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1. Introduction 
The South African state Emergency Medical Services (EMS) serve as an entry point into 
the health system for the majority of the population, in particular in previously 
disadvantaged communities. Over the past decade, there has been a growing prevalence 
of patients with chronic medical conditions such as heart disease, diabetes mellitus, 
hypertension and infectious diseases.1 Consequently, amongst the diabetic population, 
this has resulted in increased EMS callouts for patients presenting with symptomatic 
hypoglycaemia (SH).  
In the South African EMS context it is defined as a blood glucose of less than 3.5mmol/l 
with the presentation of an altered level of consciousness.2 There are multiple underlying 
causes and potentiating factors that may precipitate or exacerbate SH. Over the long-term, 
SH, especially if recurrent, may lead to increased morbidity and mortality.3 Even though 
the three levels of prehospital care (basic (BLS), intermediate (ILS) and advanced life 
support (ALS)) provide differing levels of intervention, by protocol they are all obliged to 
transport a patient to hospital unless they refuse. However, anecdotally, this refusal is 
usually strongly based on the follow-up information provided by the provider. Prehospital 
management of SH includes immediate reversal strategies, with the paramedic, if 
available, making the call to discharge post reversal or to transport to hospital, based on 
the patient’s preference. In cases where the paramedic is unavailable, ILS and BLS 
practitioners may discharge the patient based on the patient refusing further care.  
South African prehospital emergency care providers have three pharmaceutical agents 
available to reverse low plasma glucose levels, namely: oral glucose, intravenous dextrose 
and glucagon, which is aligned to the national protocols as set out by the Health 
Professions Council of South Africa.2,3 The prehospital environment is also limited in terms 
of diagnostic capabilities. Consequently the practitioner is not in a position to necessarily 
identify the cause of the SH they are treating. Furthermore, no formal “treat and discharge” 
protocols existing within the Western Cape EMS. 
The aim of this study was to determine the outcome of a sample of adult SH patients who 
were treated and discharged prehospitally, without taking them on to further definitive care. 
The primary objective was to determine the number of SH patients who experienced a 
repeat episode of hypoglycaemia after discharge and made a repeat call to EMS for a 
subsequent episode of SH within 7 days of the primary event. The secondary objectives 
were to determine if hospital admission was required subsequent to the index episode of 
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SH. In addition, this study also assessed if emergency care providers recommended 
follow-up care and provided patients with information upon discharge. 
2. Materials and Methods 
2.1 Study Setting 
The patients for this study were selected from the Northern, Southern and 
Western districts of Cape Town, South Africa, in alignment with the Western 
Cape EMS districts. These patients were identified from the specific Western 
Cape EMS district database system. This database is updated daily by data 
capturers from patient care report forms. Data fields include case types, 
response and mission times, clinical assessment and interventions with 
disposition methods. Patients with SH as a primary or secondary diagnosis, 
were selected from this database within the study period in the districts 
surveyed. 
2.2 Methodology 
A retrospective cross-sectional study design was used. Patient report forms for 
patients with a primary or secondary diagnosis of SH between May 2012 and 
September 2012 were extracted from the EMS database, yielding a 
convenience sample of 110 consecutive eligible SH cases. A telephonic follow-
up survey based on a closed-ended questionnaire was conducted within 7 days 
of the initial reversal to evaluate the outcome of the prehospital discharge. 
This study included all adult SH patients (over 18 years of age), who had a 
blood glucose level less than 3.5mmol/l and a reduced level of consciousness. 
Blood glucose levels had to have been determined by glucose monitors (i.e. no 
colorimetric visualisation methods allowed). Patients needed to have been 
discharged in the prehospital environment post-reversal using oral and/or 
intravenous and/or intramuscular hyperglycaemic agents. SH patients outside 
the Western, Southern and Northern Districts were excluded, as were those 
managed by the Cape Town Fire and Rescue Services and private sector EMS 
providers and inter-facility transfers.  During the telephonic interview, patients 
unable to speak and understand English, Afrikaans or Xhosa were excluded, as 
these represent the most common languages spoken in the Western Cape. 
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Patient report forms with illegible or absent patient and/or next of kin data were 
also excluded.  
A protocol existed for contacting patients and/ or their next of kin in a systematic 
manner for up to three tries, after which they were regarded as non-contactable. 
The telephonic surveys were conducted by the PI and a trained secondary 
reviewer in English, Afrikaans or Xhosa, dependent on the patient’s language 
preference,. The interviews were conducted off a script that was available in all 
three languages following forwards and backwards translation for accuracy. The 
figure below outlines the sampling process:  
 
 
 
 
 
 
 
 
 
Figure 1: Flowchart of outcome sample 
3. Results 
110 SH patients were eligible to be included in the telephonic interview. Of note, 
speaking to third parties, 21 (19%) of the original cases were subsequently found to 
have died following the initial EMS activation and therefore unavailable for the 
telephonic survey. The scope of this survey did not allow for the investigation of the 
presumed causes of death in these patients. The breakdown of cases is shown in 
Table 1. Of specific interest is the mean age of 56 years (SD=13) for this cohort and 
that cases were almost equally distributed between males and females. 
 
Total Sample 
N = 207 
Eligible Patients 
n = 110 
Matched Exclusion Criteria 
N = 97 
Ability to Contact 
 
Contactable & Consented to Interview 
n = 89 
 
Deceased 
n = 21 
 
Absent Data  
N = 74 
Language Exclusion 
N = 23 
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Table 1 Demographics and characteristics of cases studied 
Characteristic Value 
N 110 
Age (years)* 56 (30-83) 
Sex (male/female) 59 (54%)/51 (46%) 
Deceased 21 (19%) 
Level of prehospital care provided (including deceased cases): 
• BLS 
• ILS 
• ALS 
 
39 (35%) 
56 (51%) 
15 (14%) 
*Median (range) values 
Of the contactable 89 cases, 54 (61%) had subsequent recurrent episode/s of SH 
within 7 days of discharge by EMS, with 30 (34%) of these cases re-activating EMS in 
the same time period (Figure 2). This was independent of SH being the chief complaint 
and motivation for re-activation of EMS. 
 
 
Cases with a recurrent episode of SH used the following chronic diabetic medication: : 
12(23%) oral diabetic agents, 26(50%) insulin only and 14(27%) were oral and insulin 
diabetic agents, with 36 of the 89 (41%) eligible patients not using any medication at 
the time of the incident. 
 Hospital admission within 7 days post EMS discharge was required for 46 of the 89 SH 
cases (52%). The reasons for admission included infections (11%); hypoglycaemia 
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Figure 2: Recurrent SH episodes within 7-days post EMS discharge
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(9%); hypertension (6%); cerebrovascular accidents (6%); and hyperglycaemia (4%), 
which all may have been linked to chronic underlying diabetes mellitus. 
Prior discharge post SH reversal, follow-up and patient information was provided to 35 
(39%) of patients, and 7 (8%) unable to recall the information or whether this 
information was provided.  
Figure 3 stratifies the various levels of prehospital care provided, by recurrent SH 
episodes and provision of follow-up instructions by level of care. Notably it can be seen 
that there was a related amount of recurrent SH episodes amongst all levels of care. It 
can also be seen that despite the provision of these instructions, recurrency was still 
present. Of the 35 BLS, 45 ILS and 12 ALS managed cases; 21(24%), 24(27%) and 
9(10%) had recurrent episodes respectively. In the 89 cases, 59(66%) reactivated the 
EMS system within 7 days of the index prehospital discharge. 
It was also found that post-discharge after SH reversal patients had experienced the 
following abnormal signs and symptoms respectively: headaches with/ without 
dizziness 30 (27%), increased levels of sweating 15(14%), abdominal discomfort 14 
(13%), nausea and vomiting 12 (11%), and weakness and confusion 9(8%).  
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Figure 3: Comparison of levels of care, recurrent acute SHepisodes and follow-up 
instructions
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4. Discussion 
Symptomatic hypoglycaemia is considered a potentially serious complication of 
diabetes mellitus. SH may be disease-induced or precipitated by single or multiple 
medications used in combination.3 The treatment of prehospital SH is often limited to 
short term management strategies, with minimal capabilities for the detection of 
underlying pathologies contributing to the index event.3, 9  
In this study it was shown that recurrent SH episodes were associated with the 
reactivation of EMS resources. Deciding to discharge a patient post reversal in the 
prehospital environment, is often motivated by their refusal of hospital admission and 
further care.4 This request cannot be denied on the basis of patient autonomy and legal 
right. However, more than one third (34%) of cases eventually re-activated EMS within 
the study period, although the trigger for the second call was not ascertained as it was 
out of the scope of this study. 
The outcomes of this study can be compared to a 1998 prospective descriptive study 
from the USA, evaluating the short-term outcomes of acute SH patients post discharge. 
Then it was shown that 91% of cases had recurrent episodes within 72 hours, with 9% 
of this case re-activating EMS.4 Though the recurrence rate was higher in the US 
study, the need to reactivate EMS was higher in our local cohort. Within our prehospital 
context, this could be attributed to poor socio-economic circumstances and reduced 
access to definitive care.  
Within the Western Cape prehospital context, EMS providers utilize blood glucose 
monitors as part of their scope of practice. These monitors have inherent limitations as 
they usually require calibration, a quality assurance step not usually performed.3 Test 
strip accuracy may be influenced by expiration and extreme temperature fluctuations 
and humidity. These factors may lead to under-sensed or over-sensed blood glucose 
levels, which influences treatment and discharge strategies.7  
In cases where intravenous access cannot be established or BLS care was provided, 
oral hyperglycaemic agents are administered. These agents are short acting and may 
take a longer period of time to achieve the desired blood glucose level, thus 
potentiating neurological fallout.11 This can be linked to the outcomes of this study 
where 24% of the BLS cases experienced recurrent episodes, as oral glucose may 
have resulted in inappropriate premature discharge.  Current South African prehospital 
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ILS and ALS protocols for the management of acute SH patients include the 
administration of intravenous dextrose 50%, intramuscular or intravenous glucagon and 
oral anti-hypoglycemic agents.13 The current dextrose dosage results in a faster time to 
restore blood glucose levels to normoglyceamia. High concentration dextrose may 
induce hyperglycaemia in the short term and/ or result in renewed hypoglycaemia in 
the longer term.16 This phenomenon may also have played a role in this study in which 
27% and 10% of ILS and ALS cases respectively experienced recurrent episodes of 
SH. An additional treatment is the biosynthetic form of glucagon. It stimulates the 
release of glucose from the liver by the process of glycogenolysis, thus increasing 
blood glucose levels.11 However it is dependent on adequate endogenous glucose 
stores, which may already have been exhausted due to repeated episodes of 
hypoglycaemia, starvation, extensive liver damage or adrenal insufficiency.11 These 
factors are often unknown to prehospital providers. 
Within the Western Cape EMS system, SH patients are primarily discharged 
prehospitally if they refuse further care, or show normalisation of blood glucose levels 
and a return to their pre-episode level of consciousness on-scene. The current 
prehospital discharge practice is not sensitive to risk mitigation, as they are not 
tempered by the underlying causative factors. Recurrent SH episodes may also be 
linked to medication usage, with specific emphasis on self-administered insulin and 
dose related errors.7 Common oral agents such as the sulfonylureas, metformin and 
antibiotics have been shown to potentiate SH.8, 9, 10 The increased rate of subsequent 
SH episodes and EMS reactivation shown in this study, may have been linked to 
inadequate dosing of these agents (73% of cases were using anti- hyperglycaemic 
agents), and concomitant medication usage. The data in this study also showed that 
recurrent SH was especially evident in patients using insulin (48%) when compared to 
oral diabetic agent use only (27%) . This outcome is supported by a recent systematic 
review, in which 47% of a group of 267 patients who had been treated with insulin, 
presented with recurrent SH episodes.18  
Participants in the study period reported abnormal signs and symptoms post-discharge. 
These included headaches with/ without dizziness, increased levels of sweating, 
abdominal discomfort, nausea and vomiting, and confusion. This compares favourably 
to possible serious underlying pathologies, often independent diabetes mellitus 
precipitating the index event.15, 17   
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Current levels of prehospital care with the Western Cape EMS include Basic, BLS, ILS 
and ALS, with the vast majority of practitioners only having BLS and ILS training. In this 
study 39% and 53% of acute SH patient were managed by BLS and ILS practitioners 
respectively, with a combined SH recurrency of 51%. This may have posed a 
significant risk to patients due to the limited capabilities of this practitioners.12, 14  
In terms of follow-up instructions and patient information, this study showed that all 
levels of EMS personnel provided similar follow-up instructions, resulting in similar 
levels of recurrence (21% and 27% respectively). Thus, patient outcomes may have 
been independent of follow-up instructions. In addition, prehospital care providers 
omitted the provision of follow-up instructions or patient information prior to prehospital 
discharge, post SH reversal, in a large proportion of patients. It was also shown that in 
certain cases where these instructions were verbally provided to the patient, they were 
unable to recall such instructions. What role the manner in which the provider provided 
the information played, or whether it is associated with the poor cognitive states post 
SH reversal remains uncertain.5 Decreased levels of plasma glucose results in 
sympatho-adrenal nervous system stimulation and subsequent further drops in glucose 
may result in an increase in mortality and morbidity. Consequently, multiple recurrent 
SH episodes increase the risk for neurological deficits with resultant long term local and 
systemic morbidities.6 Furthermore these neurological deficits may have affected 
cognitive function and thus the patient’s ability to reason and make adequate decisions 
around further care strategies.7 This is not usually considered in the prehospital 
discharge process. It thus becomes a concern in this study population, in which 8% of 
cases experienced weakness and confusion post-discharge. 
Follow-up care instructions play a key role in the safe disposition and discharge of 
patients, particularly in the prehospital context. These instructions should ideally be in 
writing, evidence-based and vetted against patient outcomes (Appendix A). It should 
also include standardised information cards for the patient or bystanders to identify 
early signs and symptoms of recurrent SH. These criteria should also be linked to 
differential underlying pathologies which may flag serious comorbidities, upon which 
the patient or bystanders may appropriately act upon. However, a disadvantage of this 
may be linked to the inability of patients to interpret this information due to the 
longstanding effects of diabetes mellitus e.g. inadequate vision..  
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Subsequent to repeat activation of EMS post initial discharge, 52% of the study 
patients required hospitalisation. In a similar study conducted in 2008, 199 acute SH 
patients were followed up post reversal after prehospital discharge In this group 16% 
required hospital admission.15 It was also noted that severe cases of hypoglycaemia 
were shown to have an 18% recurrence rate within a 48-hour period.  
In a recent cohort study it was shown that patients with recurrent SH had extended 
hospital stays, increased morbidity and an increased need for specialised nursing.19 In 
another recent review of costing impact per patient presenting with hypoglycaemia in 
Spain, it was described that a single episode may cost in excess of €3500                    
(≈ZAR 52 500 at current exchange rates).20 Thus, repeat SH episodes may prove to be 
very costly for patients and funders. A major compounding factor is that of quality of life 
for the patient in terms of long-term effects of recurrent SH episodes. The scope of this 
study did not include the evaluation of the health economics the premature SH 
discharge, however the results may be extrapolated within its effects.  
 Though the study was not designed to further explore the causative factors leading up 
to the death, a high proportion of SH cases initially discharged were found to be have 
died upon telephonic follow-up. One would also have to assume that a number of those 
patients who did not respond to the telephonic challenge themselves might have died. 
In which way the original disposition strategy may have contributed remains 
speculative in specific relation to prehospital discharge post SH reversal and the 
detection of underlying causative pathologies and should form the basis of further 
investigation.  
5. Limitations 
The study population was limited to three Metropole EMS divisions, thus the data 
cannot automatically be extrapolated to the remainder of the Western Cape population 
as a whole. However, as detailed, these divisions are fairly typical and major 
differences at least within the Western Cape are not expected. In terms of the data 
collection, inconsistencies may have existed in relation to data entry. A major constraint 
in this was the identification of pure SH cases, due to often ambivalent data. A further 
limitation was the exclusion of data from Fire Services, private EMS agencies, Inter-
hospital transfers and other first responders. There was also a degree of recall bias 
during the telephonic interview; however this was limited by putting in place the 7-day 
time limit within which it was conducted. The detailed analysis of time sequences in 
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both prior and post- index SH episode relative to underlying co-morbidities was not 
possible. In terms of the deceased cases, a detailed analysis of causal pathways and 
associations to the index SH episode was not possible with the study methodology 
employed.  
With reference to the need for hospital admission post SH reversal, the diagnosis 
provided by patients or relatives may not have been on the causal pathway from the 
index SH episode. The diagnostic capabilities and provision of patient follow-up 
information by the prehospital care providers may also have been limited by levels of 
adequate training.  
This study also lacked a control group measuring the rate of recurrent visits to 
Emergency Centres and EMS callouts, for those patients managed in the Emergency 
Centres within the included EMS districts. Thus it is difficult to determine if the recall or 
TTH rate was average high or low for this service. 
6. Conclusions 
The determination of the underlying causative factors is a vital part of the treatment of 
SH. Even in this small review, 52% of patients required hospitalisation following their 
initial treatment and prehospital discharge. Therefore, effective treat and release 
protocols should be developed to prevent repeat episodes, reduce the repeat call out 
rate for SH episodes and mitigate risks These protocols should demonstrate a 
systematic approach to the management of acute SH to all levels of prehospital care 
providers. The management strategies should include effective history taking and 
diagnostic procedures to identify underlying pathologies. A key criterion here would 
include risk stratification tools. These mitigation strategies will also reduce the 
development and progression of co-morbidities and would have to be developed in 
conjunction with hospital-based Emergency Centres that would deal with these 
patients. Currently, no evidence exists on the long and short-term outcomes of the 
implementation of such strategies. This is of importance in the Western Cape and 
South Africa as a whole, as resources in both the prehospital and inhospital context are 
limited. 
Comprehensive and understandable information is an important treatment component 
when considering prehospital discharge of any patient. Effective patient and relative 
information cards should be developed and implemented to enable the patient and their 
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family to make informed choices on their further care. These cards should include 
pertinent information such as emergency contact numbers, disposition options and 
symptoms of a recurrent SH episode. Importantly it should be easy to understand and 
available in the locally relevant languages.   
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Appendix A – Prehospital Acute SH Discharge Instructions 
General Information 
The prehospital care provider has treated you for an acute episode of hypoglycaemia (low 
blood sugar levels). Your sugar levels were corrected through intravenous and/or oral 
glucose agents. He/she has tested your sugar levels and found it to have improved to 
normal levels. Please follow the instructions below: 
Follow-up Care 
• Please contact your doctor as soon as possible and inform him/her that your blood 
sugar levels had dropped below the normal levels. 
• Consult with your doctor in terms of follow up care in relation to your diabetes. 
• Limit all physical activity over the next 24hrs. These activities include sports, driving 
or any other activity where a sudden loss of consciousness may harm yourself or 
others. 
• Eat something as soon as possible and maintain regular meals. 
• Abstain from alcoholic beverages or recreational drugs over the next 24hrs. 
 
Should you experience any of the following symptoms please call 10177 from a 
landline or 112 from your mobile phone: 
• Unusual weakness, numbness or inability to move a leg or arm 
• Excessive drowsiness, confusion or slurred speech 
• Visual disturbances 
• Fainting 
• Seizures 
• Nausea or vomiting 
• Headaches 
• Any other symptoms which may be similar or worse than previous problems 
 
DO NOT SIGN THIS FORM IF YOU WANT TO BE TAKEN TO HOSPITAL FOR 
FURTHER CARE 
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Incident Number:   ________________ 
Date:     ________________ 
Patient Name & Surname: ________________ 
 
Patient Signature:   ________________ 
Paramedic:    ________________ 
 
Paramedic Signature:  ________________ 
Witness Name & Surname: ________________ 
 
Witness Signature:  ________________ 
Comments: 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
_______________________________________________________________________ 
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1. Abstract 
Background: 
Acute symptomatic hypoglycaemia (SH) is a condition, managed in the pre-hospital 
environment by emergency care providers. Post-reversal, patients often refuse 
further treatment and transport. 
Purpose: 
To retrospectively determine the number of adult symptomatic hypoglycaemic 
patients who required further intervention post-reversal following pre-hospital 
discharge in the Western Cape Metropole. 
Objectives: 
 To determine the number of SH patients who experienced a repeat episode after 
discharge. 
 To determine how many repeat calls were made to EMS for a subsequent 
episode of SH within 7 days after the primary event. 
 To determine if hospital admission was required subsequent to the index episode 
of SH. 
 To assess if follow-up care strategies were provided by pre-hospital emergency 
care providers upon discharge. 
 
Study Design: 
A retrospective cross-sectional design. 
Setting: 
This study will take place in the pre-hospital context in three Cape Town EMS 
districts. 
Study Population: 
SH patients treated by pre-hospital emergency care providers. 
Study Sample: 
Convenience sampling will be employed, which will retrospectively identify a 
minimum of 110 consecutive SH patients. 
Data Collection Methods: 
The Western Cape EMS database will be queried and applicable patient report forms 
extracted. A telephonic interview will be conducted using a closed-ended 
questionnaire. 
Statistical Methods: 
Basic statistics, including proportions and corresponding confidence intervals will be 
determined per question.  
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2. Introduction 
Acute symptomatic hypoglycaemia refers to decreased plasma glucose levels, which 
may result in sympathetic nervous system stimulation and/or altered levels of 
consciousness. Decreased plasma glucose results in decreased glucose supply to 
cerebral tissue; which may manifest as central nervous system neuro-pathologies 
including confusion, dizziness, irritability, hallucinations, focal impairment with 
resultant coma and eventual death. Furthermore, this results in the stimulation of the 
sympatho-adrenal nervous system which manifests as sweating, palpitations, 
anxiety, and hunger.1  
The prognosis of patients presenting with acute symptomatic hypoglycaemia is 
dependent on the determination of the causative factors with early effective and 
efficient increase in plasma glucose levels. In the pre-hospital setting, emergency 
care providers have three pharmaceutical agents available to reverse low plasma 
glucose levels, namely: oral glucose, dextrose and glucagon. Incorrect or 
unidentified causative factors of hypoglycaemia may result in deleterious effects on 
the outcomes as currently no treat and release protocols exist within the Western 
Cape Emergency Medical Services. This study will evaluate the effectiveness of pre-
hospital discharge within the context of patients presenting with acute symptomatic 
hypoglycaemic episodes post reversal. 
2.1 Literature Review 
Pre-hospital emergency care providers play a pivotal role in the detection and 
management of symptomatic hypoglycaemic (SH) patients. The key focus should be 
the identification of causative factors, reversal of the symptomatic hypoglycaemic 
state; and safe and efficient patient disposition strategies. 
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SH may be induced by a number of diseases (see Table 1). 
Table 1 
 Disease-Induced Symptomatic Hypoglycaemia 
1 Type 2 Diabetes – Also associated with hypertension and dyslipidaemia 
2 Renal disease 
3 Adrenal insufficiency 
4 Local & systemic infections 
5 Islet cell adenoma 
6 Liver cirrhosis 
7 Idiopathic hypoglycaemia 
8 Autoimmune compromise 
9 Pregnancy induced hypoglycaemia 
10 Renal glycosuria 
11 Hormonal insufficiencies 
  
Type 2 diabetes serves as a major contributing factor for the induction of SH. In a 
recent review it was described that in Sub-Saharan Africa, the number of people with 
Type 2 diabetes will double between the year 2000 and 2030 with a death rate of 40-
80/ 100 000 people nationally.2 Globally, the prevalence of type 2 diabetes in the 
year 2000 was 2.8% and 6.9% undiagnosed type 2 diabetes globally, which 
indicates the poor investigation of presented signs and symptoms amongst these 
patients.3 Type 2 diabetes is commonly associated with hypertension, dyslipidaemia 
and underlying cardiac pathologies.3 Patients with type 2 diabetes may average 16 
hypoglycaemic events annually which is closely related to inadequate dosage and 
administration of medications such as metformin, insulin and sulfonylurea.1 There is 
a close association between diabetes and cardiac disease. Cardiac patients 
receiving beta-blockers and salicylates as a means to mitigate dysrhythmias and 
atherosclerosis, are predisposed to incidents of SH (Table 2). 11, 12 In a recent 
review, it was described that renal disease often results in adverse drug reactions 
and as a result induces SH.4 This is caused by the impairment of medication 
elimination due to a decrease in glomerular filtration rate and creatinine clearance. 
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Adrenal insufficiency may also induce SH due to decreased secretion of adrenalin 
and noradrenalin from the adrenal medulla.5  
In chronic conditions where glycogen stores are depleted, the patient will require 
constant dextrose infusions and monitoring; otherwise a simple reversal may result 
in metabolic acidosis, respiratory failure or hemodynamic instability.8  
SH can also be caused by medication use alone or in combination with multiple 
medication dosages (see Table 2).  
  Table 2 
 Medications prone to inducing Symptomatic 
Hypoglycaemia alone or in combination 
1 Metformin 
2 Insulin 
3 Sulfonylurea 
4 Antibiotics 
5 Ethanol  
6 Beta-blockers 
7 Salicylate 
 
Secretagogues such as sulfonylureas are common causes of SH in type 2 
diabetics.9 Sulfonylurea-induced SH is correlated to inadequate caloric intake, 
pharmacological interactions and initial exposure, and thus careful monitoring of 
these patients are required.9 Antibiotics used for the treatment of infections may 
often cause symptomatic hypoglycaemia by increasing insulin secretion.7 This may 
further be potentiated in patients with type 2 diabetes sulfonylurea treatment.  
A recent study has shown that in South Africa the prevalence of alcohol abuse 
occurs at 6%.10 This indicates an increased potential for alcohol induced SH. Ethanol 
causes potent SH responses which results in decreased endogenous glucose 
production and glycogenolysis, thus presents with life-threatening consequences.   
 
When dealing with the pre-hospital treatment of SH, a third aspect to consider is the 
means of diagnosis. Blood glucose monitors are the mainstay diagnostic modality; 
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however they have a number of shortfalls. These include calibration errors, test strip 
accuracy correlated to expiration and external environmental factors. In a recent 
hospital study evaluating the accuracy of blood glucose monitors, it was found that 
these monitors often over-sensed or under-sensed blood glucose readings.13 Thus, 
episodes of hypoglycaemia may be underdiagnosed and those of hyperglycaemia 
over diagnosed, which could  be extrapolated to the prehospital setting as the similar 
blood glucose monitors are used. 
Glucose monitors have varying sensing levels toward different sugars thus may 
produce stable levels of the incorrect sugar type. Ketones may also cross-react on 
strips resulting in false positive or false negative results. These factors may be 
mitigated against in hospitals as a result of on-going observation and monitoring as 
well as recourse to laboratory checks.  
In the South African pre-hospital context, pharmacological management of SH 
includes the administration of oral glucose (oral hypoglycaemic agents), intravenous 
dextrose or glucagon.14 Oral hypoglycaemic agents may result in recurrent SH 
episodes. In a recent systematic review its was shown that the administration of oral 
hypoglycaemic agents may result in recurrent SH episodes.15  
In the South African pre-hospital context, a major component of EMS systems are 
Basic Life Support providers, where oral hypoglycaemic agents are the only 
pharmacological SH agents which may be administered within their scope of 
practice. Oral hypoglycaemic agents can also be administered by Intermediate and 
Advanced Life Support practitioners in the absence of intravenous access for the 
administration of dextrose. In the South African pre-hospital context, current 
protocols include the administration of 50% intravenous dextrose.14 Studies have 
shown that high concentrations of dextrose may result in an excessive increase in 
blood glucose levels to hyperglycaemic levels.19, 20 This may pose as a potential risk 
to SH patients and lead to a false sense of security where patients may refuse 
transport to definitive care with resultant pre-hospital discharge by emergency care 
providers. This may also result in rapid blood glucose level decrease with recurrent 
SH.  
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Effective management of SH patients in the pre-hospital context includes safe and 
efficient disposition strategies. Patients presenting with SH in the pre-hospital 
environment often prefer discharge with no hospital admission post SH 
reversal.16,17,21 Pre-hospital discharge of SH post reversal has been shown to be 
safe in primarily in Type 1 diabetic patients as they had received formal patient 
education which may prevent recurrent SH episodes.18, 23  
Pre-hospital discharge of SH patient post-reversal may present with inherent 
complications. In a recent prospective case series study it was concluded that pre-
hospital discharge post-reversal led to an 8% complication rate.23 Pre-hospital 
discharge post reversal has been shown to be effective in conditions where 
adequate discharge information is provided to patients to prevent recurrent SH 
episodes.24,25 In a recent follow-up survey evaluating outcomes of 203 patient post 
discharge within 48 hours, it was concluded that there were 8% recurrent episodes, 
5% repeat Emergency Medical Service callouts and 11% hospital admissions upon 
recurrent callout.26 Pre-hospital discharge post SH reversal may expose patients to 
clinical risk due to incorrect diagnosis, pharmacological treatment and ineffective 
referral pathways with patient education and advice provided by pre-hospital 
emergency care providers. 
2.2 Motivation for Study 
South African pre-hospital emergency care is a complex field which has rapidly 
advanced over the past decade, and serves as an entry point into the health system 
for patients, especially in previously disadvantaged communities. Over the past 
decade there has been a growing incidence of patients with chronic medical 
conditions such as heart disease, diabetes mellitus, hypertension and infectious 
diseases, thus increasing the number of patients accessing Emergency Medical 
Services.  
There is an increased incidence of callouts are received for patients presenting with 
symptomatic hypoglycaemia.SH is a complex condition with varying causes which 
may be induced by underlying causes and inefficient management may potentiate 
these causes thus increasing morbidity and mortality. Pre-hospital management of 
SH includes reversal strategies and discharge post reversal of SH. Currently no 
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discharge protocols exist within the context of pre-hospital discharge of SH patients 
post-reversal due to a lack of evidence based on the outcomes of these patients, 
although performed on a daily basis. This study will identify the outcomes of these 
patients post-discharge following the current practice of pre-hospital discharge by 
emergency care providers.  
2.3 Research Question 
Are subsequent interventions required to treat further episodes of symptomatic 
hypoglycaemia in adults who were treated for the same in the pre-hospital context by 
Emergency Medical Care providers and subsequently discharged in the field? 
2.4 Aim 
To retrospectively determine the outcomes of adult symptomatic hypoglycaemic 
patients who were treated and discharged pre-hospitally.   
2.5 Objectives 
 To determine the number of SH patients who experienced a repeat episode of 
hypoglycaemia after discharge. 
 To determine how many repeat calls were made to EMS for a subsequent 
episode of SH within 7 days after the primary event. 
 To determine if hospital admission was required subsequent to the index episode 
of SH. 
 To assess if follow-up care strategies were provided by pre-hospital emergency 
care providers upon discharge. 
3. Methodology 
3.1 Study Design 
A retrospective cross-sectional study design will be used as it will provide individual 
characteristics, effect of risk factors and information with regard to an event 
outcome. Patient report forms from symptomatic hypoglycaemic patients managed 
by pre-hospital emergency medical care providers will be extracted from the EMS 
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database. These forms will be collected from the Western Cape Emergency Medical 
Services Metropolitan Area – Northern, Southern and Western Districts. A minimum 
of 110 patients will be interviewed, matching the inclusion criteria. Patients will be 
contacted via telephone to conduct a telephonic interview. If a patient is unreachable 
after the first attempt, a second attempt will be made 24 hours later. However, if the 
patient remains unreachable, they will be excluded from the study. Patients will also 
be excluded if no or illegible telephone numbers occur on the patient care report 
form. A follow-up survey using a closed-ended questionnaire (Annexure 1) will be 
applied to evaluate the short-term outcomes (7 days) efficacy of pre-hospital 
discharge of hypoglycaemic patients’ post-reversal. 
3.2 Study Population 
The Western Cape Provincial mortality due to diabetes was 100 per 100 000 
population as at 2006, with higher prevalence rates among Coloureds, Indians and 
Whites.27 These population groups are mostly located in the Northern, Southern and 
Western regions. Collectively these regions account for most of the Western Cape’s 
population due to its dense residential occupancies. The Western Cape Emergency 
Medical Services (EMS) often responds to SH patients as a result of poor glucose 
control with diabetes. The Western Cape EMS (Metropole region) responds to 
approximately 10 000 incidents monthly, of which a percentage includes SH patients 
with poor glucose control; with underlying diabetes. In relation to the population 
distribution, a great percentage of these incidents occur in these regions.  
The patients for this study will selected from the Northern, Southern and Western 
regions of the Western Cape in alignment to the EMS districts. These patients will 
be identified from the Western Cape EMS district data system. Patients who 
presented to EMS in these districts with symptomatic hypoglycaemia as a primary or 
secondary diagnosis, which post-reversal and discharged pre-hospitally will be 
selected for this study. 
 
 
 
Part C – Research Proposal 
11 
 
3.3 Sampling 
Convenience sampling will be employed, which will retrospectively identify a 
minimum of 110 SH patients who had presented to the three metropolitan districts 
and was discharged post-hypoglycaemic reversal. A  target sample of 110 SH cases 
will be aimed for to compensate for possible attrition. These patients will be 
contacted and interviewed within 7 days of the initial callout. The process will be 
conducted until a total of 110 patients that have met the criteria to be interviewed 
have been reached across the three EMS districts.  
3.3.1 Inclusion Criteria 
This study will include all adult symptomatic hypoglycaemic patients (over 18 years 
of age) who presented to the Western Cape EMS Metropolitan Area – Western, 
Southern and Northern Districts. Symptomatic criteria would include patients with a 
blood glucose level less than 3.5mmol/l and with an altered level of consciousness. 
This study will only include patients where blood glucose levels were determined by 
glucose monitors. Accu-Chek® Active monitors will be used (standard issue within 
the Western Cape EMS), as these monitors are self-calibrated upon insertion of 
coding chip which accompanies each specific test strip package. Expiry dates of test 
strips are regularly checked by pharmacists upon issue to practitioners. These test 
strips are only valid for a three month period upon opening of the package. The 
study will include patients matching these criteria in relation to primary pre-hospital 
management by a basic, intermediate or advanced life support pre-hospital 
emergency medical practitioners. Only adults (over the age of 18) will be included. 
This study will only include patients with the above criteria, who were discharged in 
the pre-hospital environment. 
 2.3.1. Exclusion Criteria 
This study will exclude symptomatic hypoglycaemic patients outside the Western 
Cape EMS Metropolitan Area – Western, Southern and Northern Districts. 
Symptomatic hypoglycaemic patients managed by the Cape Town Fire and Rescue 
Services; and private sector Emergency Medical Service providers will be excluded. 
Symptomatic hypoglycaemic patients managed by primary facilities requiring inter-
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facility transfer via EMS to secondary or tertiary facilities omitted. Patients with 
asymptomatic hypoglycaemia or low blood glucose in the absence of an altered level 
of consciousness will not be included.  During the telephonic interview, patients 
unable to speak and understand English, Afrikaans or Xhosa will be excluded. 
Patient report forms with illegible or absent patient and/or next of kin data will also be 
excluded. Upon introduction in the telephonic interview, the investigator will seek 
consent from the patient and given the option to withdraw from the study at any point 
during questioning. Patients not providing consent or choosing to withdraw from 
participation will also be excluded from this study. 
3.4 Data Collection and Management 
Data for this study will be collected from the Western Cape EMS district data capture 
tools, patient report forms and telephonic interviews (through questionnaires). The 
Western Cape EMS – Northern, Western and Southern Districts’ monthly incident 
statistics will be retrieved through databases. These incident statistics will identify all 
diabetic incidents for these regions, hence identifying the pre-hospital diabetic 
incidents. This data will provide specific dates, times and location of incidents in 
order to retrieve patient care report forms (Annexure 2). Patient care report forms will 
be collected from the Western Cape EMS central data store. Patient care report 
forms will be used as a tool to retrieve patient contact details to conduct the 
telephonic closed-ended questionnaire. Illegible entries within patient care report 
forms will be excluded. A record will be kept with regards to the number of patients 
thus excluded. Illegible or inconsistent entries will likewise be excluded from the 
study and reported upon. To avoid duplication of data, each SH case will be 
removed from the data sheet and the corresponding patient care report form.  
The patients’ past medical and medication history will be captured from the patient 
report form and confirmed through the telephonic questionnaire. The EMS level of 
care data will also be captured. 
The telephonic survey will be conducted in English, Afrikaans or Xhosa dependent 
on the patient’s language preference, as these are the most common languages in 
the Western Cape.31 The interview will be conducted by the principal investigator to 
cater for English and Afrikaans participants, and a secondary interviewer to conduct 
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the Xhosa survey if required. This secondary interviewer will be trained by the 
principal investigator with the aid of simulated interviews. To ensure accurate 
translation, forwards and backwards translation will be applied. If a patient is 
unreachable after the first attempt, the patient care report form will be put aside and 
a second attempt will be done within 24 hours. However, if the patient remains 
unreachable, they will be passed-over. If the telephone details provided are that of a 
third party, an attempt will be made to get the telephonic contact details of the 
patient, however if contact cannot be made due to any reason telephonically in this 
24 hour period, the patient will be passed over. 
Each completed questionnaire will be bound to a copy of the corresponding patient 
report form with copies of district statistics which will be held in lever-arch files 
secured in a lockable metal cabinet at the Western Cape EMS – College of 
Emergency Care. Inability to contact patients during the telephonic interview 
sessions will be noted and reasoning captured and analysed. Prior administration of 
the telephonic questionnaire, the procedure shall be explained to the patient.  
Throughout the data collection phase duplicate copies of these files and compact 
discs will be made with corresponding updated data. These duplicate data files will 
be stored with the principal investigator. 
Data from the questionnaires will be retrieved and captured onto Microsoft Excel 
2010, where it will be backed up on external USB storage devices and remote 
storage server which will only be accessible to the principal investigator and 
supervisors of this study. The captured data will also be encrypted and password 
protected to limit access to the principal investigator and supervisor upon request. 
The retrieved data will be analysed in specific relation to the aims and objectives of 
this study. 
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4. Statistical and Data Analysis 
4.1 Sample Analysis 
The primary analysis method in this study will be the calculation of the proportion 
and corresponding confidence interval for the questions listed in the telephonic 
questionnaire data capture sheet.  The required sample size was therefore based on 
this proportion and achieving the desired precision in the 95% confidence interval.  A 
sample size of 93 valid responses will be sufficient to achieve a 10% precision in the 
estimate of the population proportion. 
4.2 Data Analysis 
Microsoft ExcelTM 2010 will be used to capture the data and STATISTICATM version 
10 will be used to analyse the data.  
The primary objective of the study is to determine the number of SH patients who 
experienced a repeat hypoglycaemic episode after discharge in the pre-hospital 
environment. 
Summary statistics will be used to describe the variables.  The distributions of 
variables will be presented with histograms and/or frequency tables. Medians or 
means will be used as the measures of central location for ordinal and continuous 
responses and standard deviations and quartiles as indicators of spread. 
Relationships between two continuous variables will be analysed with regression 
analysis and the strength of the relationship measured with the Pearson correlation, 
or Spearman correlation, if the continuous variables are not normally distributed. If 
one continuous response variable is to be related to several other continuous input 
variables, multiple regression analysis will be used and the strength of the 
relationship measured with multiple correlation. 
The relationships between continuous response variables and nominal input 
variables will be analysed using appropriate analysis of variance (ANOVA). The 
ordinal response variables will be compared to a nominal input variable, non-
parametric ANOVA method will be used. For completely randomized designs the 
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Mann-Whitney test or the Kruskal-Wallis test will be used and for repeated measures 
the Wilcoxon- or Friedman tests will be used.   
The relation between two nominal variables will be investigated with contingency 
tables and likelihood ratio chi-square tests. A p-value of p< 0.05 will represent 
statistical significance in hypothesis testing and 95% confidence intervals will be 
used to describe the estimation of unknown parameters. 
5. Ethical and Legal Considerations 
Primarily, patient autonomy and confidentiality will be maintained throughout the 
phases of this study. Verbal consent will be obtained telephonically as per the 
Helsinki protocol. All patients will be informed of the background, aims and 
objectives of this study (Annexure 3). Permission shall be obtained and documented 
(Annexure 4) from the Western Cape Department of Health EMS to obtain data from 
their internal databases and patient care report forms. These will only be made 
available to the principal investigator and supervisors of this study. All participants 
will be made aware of this facility. Interviews conducted by participants including the 
principal investigator will complete a patient confidentiality form (Annexure 5).  All 
interview data will only be made available to the principal investigator, supervisors 
and the Western Cape Department of Health. 
During the telephonic interviews, patients may be dissatisfied with services rendered 
by the Western Cape Department of Health EMS practitioners. These patients will be 
directed to the specific Continuous Quality Improvement EMS official within their 
district. 
6. Limitations 
This study will only investigate SH patients managed in the pre-hospital setting by 
the Western Cape Department of Health – EMS practitioners in three districts. 
Patients managed by Cape Town Fire & Rescue Services, and private sector EMS 
providers in these and other districts will be excluded, therefore limiting external 
validity. 
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The recruitment process of SH patients into this study may affect internal validity. 
Selection bias may occur as a result of patient pass-over instances.  This may also 
occur as a result of patients refusing to partake in the study, illness, death, migration 
or missing data.  
This study will only include cases where Accu-Chek® Active glucose monitors were 
used as it is standard issue to Western Cape EMS personnel. Colourmetric blood 
glucose levels determination using test strips will be excluded and other brands of 
glucose monitors. As a result of this, bias toward Accu-Chek® Active glucose 
monitors may be displayed.  
The study survey will not be conducted in all eleven official languages of South 
Africa; hence some patients will be excluded from the sample group.  
A non-validated closed-ended questionnaire will be used to survey patients. Closed-
ended questions will enable the allocation of quantitative methods which will allow for 
statistical interpretation. These types of questions are more specific, thus similar 
meanings during interview responses will be interpreted. However, the questionnaire 
may result in leading or suggestive answers wanted by the investigator. Closed 
ended questionnaires also do not allow room for further discussion and emergence 
of themes related which may contribute to the aims and objectives of this study.  
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7. Resources 
7.1 Available Resources 
 Description Source 
1 Statistical Services Centre for Statistical Consultation, 
Stellenbosch University 
UCT and US Joint Division of 
Emergency Medicine 
2 Travel Services Principal Investigator 
3 Telephone communication Western Cape Department of Health 
EMS – Contact Centre 
4 Internet access and email facilities Principal Investigator 
5 Computer including Microsoft Word and 
Excel 
Principal Investigator 
6 Printing and copying Principal Investigator 
 
7.2 Budget 
Budget 
February – December 2012 
Item Description  Unit cost No. of 
Units 
Total cost 
1. Communication Phone services   R0.00 
 Internet and Email services R100.00/ 
month 
8 R800.00 
2. Specialized 
services 
Bio statistical Services R185.00/hr 10 R1850.00 
3. Office supplies, 
printing & 
reproduction for 
data collection 
Printing R0.40 / 
page 
1000 R400.00 
4. Travel to sites Travel cost  R3.61/ km 500 R1805.00 
Total Direct Costs    R5855.00 
Indirect Costs (12%)    R702.60 
Total    R5557.60 
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8. Reporting and Implementation of Results 
Upon conclusion of the study, the results will be made available to the Western Cape 
Emergency Medical Services and the Health Professions Council of South Africa. 
These results will serve as a platform for further investigation into the discharge of 
SH patients post-reversal in other similar prehospital environments. Hence, this will 
encourage the review of current practice in the management and discharge of SH 
patient’s post-reversal.  
It will also be made available to the University of Cape Town’s Department of 
Emergency Medicine and other Paramedical training institutions, locally and 
nationally. Dissemination to pre-hospital emergency care providers’ training 
institutions will raise awareness and responsiveness to the management and 
discharge of these patients. 
The outcomes of this study will serve as the basis for future research within the 
context of pre-hospital discharge for symptomatic hypoglycaemic patients within the 
Western Cape. This study will demonstrate the safety and efficacy of pre-hospital 
discharge of hypoglycaemic patient’s post-reversal by emergency care providers. 
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ANNEXURE 1 
PATIENT QUESTIONNAIRE 
 
Incident Date:  ________________  Incident Time: _____ 
Dispatch No:   ________________  Shift:   _____  
Patient Report Form No: ________________  Patient Age:  _____ 
Patient Gender: _____     Patient Language: _____ 
Ambulance Diagnosis: ________________ 
Prehospital Level of Care (circle):   
Interviewer: ________________    Interview Date: _____ 
 
  
Question   
1 
Was this your first episode of low blood sugar 
levels when you activated the Ambulance 
Service? 
Yes No 
2 
What diabetic medication are you utilising?  
( please √) 
Oral agents only 1 
Insulin only 2 
Oral agents & 
insulin 
3 
None 4 
3 
Did you have to go to the hospital within 7 days 
after discharge by EMS? 
Yes No 
4 
If yes to question 4, what was the hospital 
diagnosis? 
 
5 
After discharge by EMS, did you experience 
any of the following within 7 days of discharge?  
( please √) 
Nausea & vomiting  
Headaches or 
dizziness 
 
Increased sweating 
levels 
 
Abdominal 
discomfort 
 
Weakness & 
confusion 
 
B I A 
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6 Do you have a glucose monitor at home? Yes No 
7 
When you experienced any of the above, did 
you or your family check your glucose (sugar) 
levels with your glucometer? 
Yes No 
8 
If yes to question 7, was it low, high or normal? 
( please √) 
Low 1 
Normal 2 
High 3 
9 
Upon discharge by the ambulance staff, did 
they provide you with follow-up instructions 
after your first episode of symptomatic 
hypoglycaemia should you have felt ill again?  
( please √) 
Yes 1 
No 2 
Unable to recall 3 
10 
Did you have to call the ambulance service 
within 7 days after discharge by the Ambulance 
Services? 
Yes No 
11 
Post discharge by the ambulance personnel, 
did you have another episode of symptomatic 
hypoglycaemia within 7 days? 
Yes No 
 
Reason for inability to contact:   Inclusion Criteria Check List to PRF: 
 
Reason 
Please  
√ 
    
Criteria 
Please  
√ 
1 Contactable 
    1 Northern/ Western/ 
Southern District 
 
2 No answer     2 Adult > 18yrs  
3 Wrong number     3 GCS < 15/15  
4 Refused 
    4 Discharged by EMS post 
reversal 
 
5 Not available        
6 Ill/ Hospital        
7 Deceased     
 
ATTACH TO CORRESPONDING COPY OF PATIENT CARE REPORT FORM  
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ANNEXURE 2 
DATA CAPTURE SHEET 
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ANNEXURE 3 
PATIENT INFORMATION SHEET FOR TELEPHONIC INTERVIEW 
 
TITLE OF THE RESEARCH PROJECT:   Pre-hospital Discharge of Hypoglycemic 
Patients Post-Reversal 
REFERENCE NUMBER:    BLYMOH001 
PRINCIPAL INVESTIGATOR:    Mohamed Ridhaa Booley  
ADDRESS: University of Cape Town – Joint 
Division of Emergency Medicine 
CONTACT NUMBER:     072 672 2223/ 021 938 6730  
The following will be read to the patient over the telephone 
Good Day 
My name is Mohamed Booley. Do you speak and understand English, Afrikaans or 
Xhosa? 
I would like to invite you to participate in a research project that aims to look at the 
current practice of discharging patients directly after intervening during an episode of 
low blood sugar to which the ambulance crew responded. 
Also, your participation is entirely voluntary and you are free to decline to participate.  
If you say no, this will not affect you negatively in any way whatsoever.  You are also 
free to withdraw from the study at any point, even if you do agree to take part. 
This study has been approved by the Health Research Ethics Committee (HREC) at 
the University of Cape Town. 
 
This study will consist of a questionnaire, comprising of 11 questions which will 
evaluate your experience post discharge by ambulance personnel and will take 
approximately 5 minutes to complete. 
 
Please note that this call is record for record purposes and all personal information 
will be kept confidential. 
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Patient Information Checklist 
1 Do you understand that which I have explained to you?  
2 Do you consent to partake in this study  
 
 
Mohamed R. Booley 
Principal Investigator 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part C – Research Proposal 
28 
 
ANNEXURE 4 
INSTITUTION AUTHORIZATION 
TITLE OF THE RESEARCH PROJECT:   Pre-hospital Discharge of Hypoglycemic 
Patients Post-Reversal 
REFERENCE NUMBER:    BLYMOH001 
PRINCIPAL INVESTIGATOR:    Mohamed Ridhaa Booley  
ADDRESS: University of Cape Town – Joint 
Division of Emergency Medicine 
CONTACT NUMBER:     072 672 2223/ 021 938 6730  
 
To whom it may concern, 
 
I ……………………………………………………………………………….. representing 
the Western Cape Government Department of Health-Emergency Medical Services 
under his/her capacity as Director: Western Cape Emergency Medical Services  - 
herewith authorize that this study be conducted in light of the principal investigator 
retrieving patient care report which will provide critical data to enable the 
administration of a telephonic interview for hypoglycaemic patients discharged in the 
pre-hospital setting. I also herewith authorize the principal investigator to make use 
of the Western Cape Emergency Medical Services contact centre in order to conduct 
a telephonic survey to meet the aims and objectives of the research project. 
It is accepted by the principal researcher that all legal and ethical aspects of this 
study will be considered and mitigated as outlined in the presented study proposal 
and adhered to at all times. 
Signed at (place) ......................…........…………….. On (      ) …………....……….. 
2012. 
 
 ..............................................................   ............................................................  
 
Signature            Print Name in full 
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ANNEXURE 5 
PATIENT CONFIDENTIALITY – TELEPHONIC INTERVIEWER 
TITLE OF THE RESEARCH PROJECT:   Pre-hospital Discharge of Hypoglycemic 
Patients Post-Reversal 
REFERENCE NUMBER:    BLYMOH001 
PRINCIPAL INVESTIGATOR:    Mohamed Ridhaa Booley  
ADDRESS: University of Cape Town – Joint 
Division of Emergency Medicine 
CONTACT NUMBER:     072 672 2223/ 021 938 6730  
 
I ______________________________________ understand and acknowledge that:  
 
1. I shall respect and maintain the confidentiality of all discussions, deliberations, 
patient care records and any other information generated in connection with 
individual patient care, risk management and/or peer review activities.  
 
2. It is my legal and ethical responsibility to protect the privacy, confidentiality 
and security of all medical records, proprietary information and other 
confidential information relating to the Provincial Government Western Cape 
Department of Health – Emergency Medical Services and its affiliates, 
including business, employment and medical information relating to our 
patients, members, employees and health care providers. 
 
3. I shall only access or disseminate patient care information in the performance 
of my assigned duties and where required by or permitted by law, only with 
the express approval of my supervisor or designee. I shall make no voluntary 
disclosure of any discussion, deliberations, patient care records or any other 
patient care, peer review or risk management information, except to persons 
authorized to receive it. 
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4. I agree to discuss confidential information only in the work place and only for 
job related purposes and to not discuss such information outside of the work 
place or within hearing of other people who do not have a need to know about 
the information. 
 
5. I understand that the law specially protects psychiatric and drug abuse 
records, and that unauthorized release of such information may make me 
subject to legal and/or disciplinary action. 
 
6. My obligation to safeguard patient confidentiality continues after my 
termination of services with the principal investigator 
 
I hereby acknowledge that I have read and understand the foregoing information and 
that my signature below signifies my agreement to comply with the above terms. In 
the event of a breach or threatened breach of the Confidentiality Agreement, I 
acknowledge that the University of Cape Town, its partners and affiliates involved in 
this study may, as applicable and as it deems appropriate, pursue disciplinary action 
via internal or external legal processes.  
 
Signed at (place) ......................…........…………….. On (      ) …………....……….. 
2012. 
 
 ..............................................................   ............................................................  
 
Signature            Print Name in full 
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UNIVERSITY OF CAPE TOWN 
" 
04 May 2012 
HREC REF: 160/2012 
Mr M Booley 
c/o Dr T Welzel 
Department of Surgery 
Emergency Medicine 
Dear Mr Booley 
Health Sciences Facultv 
HUman Research Ethics Committee 
Room E52-24 Groote Schuur Hospital Old Main Building 
Observatory 7925 
Telephone [021] 406 6338 • Facsimile [021] 406 6411 
e-mail: shuretta.thomas@uct.ac.za 
PROJECT TITLE: CROSS-SECTIONAL ANALYSIS OF THE SHORT TERM OUTCOMES OF 
PATIENTS RECEIVING PREHOSPITAL TREATMENT FOR SYMPTOMATIC HYPOGLYCAEMIA IN 
CAPE TOWN. 
Thank you for responding to the issues raised by the Faculty of Health Sciences Human Research 
Ethics Committee in your letter received on 3,d May 2012. 
It is a pleasure to inform you that the HREC has formally approved the above-mentioned study. 
Approval is granted for one year till the 15th May 2013 
Please submit a progress form, using the standardised Annual Report Form if the study continues 
beyond the approval period. Please submit a Standard Closure form if the study is completed within 
the approval period. 
(Forms can be found on our website: www.health.uct.ac.zafresearchfhumanethicsfforms) 
Please note that the ongoing ethical conduct of the study remains the responsibility of the principal 
investigator. 
Please quote the HREC. REF in all your correspondence. 
Yours Sincerely 
~~O~~AN 
PF CHAIRPERSON, HSF HUMAN ETHICS Federal Wide Assurance Number: FWA00001637 . 
Institutional Review Board (IRB) number: IRB00001938 
This serves to confirm that the University of Cape Town Human Research Ethics Committee complies 
to the Ethics Standards for Clinical Research with a new drug in patients, based on the Medical 
Research Council (MRC-SA), Food and Drug Administration (FDA-USA), International Convention on 
Harmonisation Good Clinical Practice (ICH GCP) and Declaration of Helsinki guidelines. 
The Human Research Ethics Committee granting this approval is in compliance with the ICH 
Harmonised Tripartite Guidelines E6: Note for Guidance on Good Clinical Practice (CPMPjICHj135j95) 
and FDA Code Federal Regulation Part 50, 56 and 312. 
s.thomas 
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ANNEXURE 4 
INSTITUTION AUTHORIZATION 
TITLE OF THE RESEARCH PROJECT: 
REFERENCE NUMBER: 
PRINCIPAL INVESTIGATOR: 
ADDRESS: 
CONTACT NUMBER: 
To whom it may concern , 
Pre-hospital Discharge of Hypoglycemic 
Patients Post-Reversal 
BLYMOH001 
Mohamed Ridhaa Booley 
University of Cape Town - Joint 
Division of Emergency Medicine 
072 672 22231 021 938 6730 
~ ,C\&'rA f'n . '\<..ob0~CI' I .. . ........ ... . ......... ...... ... . ~~...... .. . .... ... .. .. . .... ... ....... ... .. ...... .... representing 
the Western Cape Government Department of Health-Emergency Medical Services 
under his/her capacity as Director: Western Cape Emergency Medical Services -
herewith authorize that this study be conducted in light of the principal investigator 
retrieving patient care report which will provide critical data to enable the 
administration of a telephonic interview for hypoglycaemic patients discharged in the 
pre-hospital setting. I also herewith authorize the principal investigator to make use 
of the Western Cape Emergency Medical Services contact centre in order to conduct 
a telephonic survey to meet the aims and objectives of the research project. 
It is accepted by the principal researcher that all legal and ethical aspects of this 
study will be considered and mitigated as outlined in the presented study proposal 
.. ... ..... ~. : .. ~ .. .-.~~~~ ....... ... .. . 
Signature Print Name in full 
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DESCRIPTION
.
The African Journal of Emergency Medicine (AfJEM) is the official journal of the African Federation for
Emergency Medicine. It is an international, peer-reviewed journal aimed in particular at supporting
emergency care across Africa. AfJEM publishes original research, reviews, brief reports of scientific
investigations, case reports as well as commentary and correspondence related to topics of scientific,
ethical, social and economic importance to emergency care in Africa. Articles will be of direct
importance to African emergency care, but may have originated from elsewhere in the world.
AfJEM publishes manuscripts of international quality. This is ensured through a process of rigorous
peer-review where manuscripts are evaluated for accuracy, novelty and importance. It is however
recognised that African researchers in emergency care are disadvantaged in the available range
of journals into which they can publish their work. The editorial team is aware that this is due to
many reasons, including that developing world topics are often considered too basic for western
Emergency Medicine journals, or that topics are concerned with conditions which are largely irrelevant
to those audiences. Furthermore, the quality of submitted manuscripts is often lower than acceptable
international journal standards due to inadequate research training. AfJEM is dedicated to support all
authors who wish to make an attempt at publication on an African Emergency care topic. In order to
maintain and produce a high quality, international standard Emergency Medicine journal, AfJEM has
devised Author Assist. AfJEM uses a team of experienced volunteers to help improve the quality of
manuscripts before peer-review submission. In this capacity AfJEM may, in suitable cases, be able to
direct authors towards publication of suitably significant findings of an international interest in other
international journals. AfJEM's Author Assist functions independently from peer-review and assistance
rendered does not constitute an automatic indication of publication, but rather a process to improve
an author's chances in succeeding at peer review.
AfJEM is uniquely tailored to the needs and requirements of emergency care workers dedicated to
improving emergency medicine in Africa. It will be ideal reading material for physicians, nurses and
pre-hospital care workers wishing to improve their knowledge on general emergency medicine, trauma
care, paediatrics, injury and disease prevention, service improvement, policy and ethics, disaster
preparedness and response, and all other aspects of emergency care. In keeping with the African
Federation for Emergency Medicine, it is our aim to be recognised as the international voice of quality
emergency medical care in Africa.
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GUIDE FOR AUTHORS
.
BEFORE YOU BEGIN
Ethics in publishing
For information on Ethics in publishing and Ethical guidelines for journal publication see
http://www.elsevier.com/publishingethics and http://www.elsevier.com/ethicalguidelines.
Policy and ethics
The work described in your article must have been carried out in accordance with The Code
of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving
humans http://www.wma.net/en/30publications/10policies/b3/index.html; EU Directive 2010/63/EU
for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm;
Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. This
must be stated at an appropriate point in the article.
Conflict of interest
All authors must disclose any financial and personal relationships with other people or organisations
that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include
employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/
registrations, and grants or other funding. See also http://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission of an article implies that the work described has not been published previously (except
in the form of an abstract or as part of a published lecture or academic thesis), that it is not under
consideration for publication elsewhere, that its publication is approved by all authors and tacitly or
explicitly by the responsible authorities where the work was carried out, and that, if accepted, it
will not be published elsewhere including electronically in the same form, in English or in any other
language, without the written consent of the copyright-holder.
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and
design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the
article or revising it critically for important intellectual content, (3) final approval of the version to
be submitted.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of
accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove an author,
or to rearrange the author names, must be sent to the Journal Manager from the corresponding author
of the accepted manuscript and must include: (a) the reason the name should be added or removed,
or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that
they agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed. Requests that are not sent by
the corresponding author will be forwarded by the Journal Manager to the corresponding author, who
must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal
Editors of any such requests and (2) publication of the accepted manuscript in an online issue is
suspended until authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange
author names in an article published in an online issue will follow the same policies as noted above
and result in a corrigendum.
Clinical trial results
In line with the position of the International Committee of Medical Journal Editors, the journal will not
consider results posted in the same clinical trials registry in which primary registration resides to be
prior publication if the results posted are presented in the form of a brief structured (less than 500
words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings)
is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all
posting in registries of results of the same or closely related work.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for
more information please contact the society.)
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Retained author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred
to: http://www.elsevier.com/authorsrights.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or
preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in
the collection, analysis and interpretation of data; in the writing of the report; and in the decision to
submit the article for publication. If the funding source(s) had no such involvement then this should
be stated. Please see http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose articles appear in
journals published by Elsevier, to comply with potential manuscript archiving requirements as specified
as conditions of their grant awards. To learn more about existing agreements and policies please visit
http://www.elsevier.com/fundingbodies.
Open access
This journal offers you the option of making your article freely available to all via the ScienceDirect
platform. To prevent any conflict of interest, you can only make this choice after receiving notification
that your article has been accepted for publication. The fee of $3,000 excludes taxes and other
potential author fees such as colour charges. In some cases, institutions and funding bodies have
entered into agreement with Elsevier to meet these fees on behalf of their authors. Details of these
agreements are available at http://www.elsevier.com/fundingbodies. Authors of accepted articles,
who wish to take advantage of this option, should complete and submit the order form (available at
http://www.elsevier.com/locate/openaccessform.pdf). Whatever access option you choose, you retain
many rights as an author, including the right to post a revised personal version of your article on your
own website. More information can be found here: http://www.elsevier.com/authorsrights .
Language and language services
Please write your text in UK English by setting your wordprocessor to English (U.K.). Authors
who require information about language editing and copyediting services pre- and post-submission
please visit http://webshop.elsevier.com/languageediting or our customer support site at http://
support.elsevier.com for more information.
Submission
Submission to this journal proceeds totally online and you will be guided stepwise through the creation
and uploading of your files. The system automatically converts source files to a single PDF file of the
article, which is used in the peer-review process. Please note that even though manuscript source
files are converted to PDF files at submission for the review process, these source files are needed for
further processing after acceptance. All correspondence, including notification of the Editor's decision
and requests for revision, takes place by e-mail removing the need for a paper trail.
Submit your article
Please submit your article via http://ees.elsevier.com/afjem/
Referees
Please submit, with the manuscript, the names, addresses and e-mail addresses of three potential
referees. Note that the editor retains the sole right to decide whether or not the suggested reviewers
are used.
TYPES OF ARTICLES
Original Research: Original studies of basic or clinical investigations in areas relevant to emergency
medicine. References and a structured abstract are required. Maximum length: 3,000 words, 5 tables
and/or figures, plus the abstract (300 words) and references (max 50).
Brief Research Reports: Reports of preliminary data and findings or studies with small numbers
demonstrating the need for further investigation. References and a structured abstract are required.
Maximum length: 1,500 words, plus the abstract (max 300 words) and references (max 10) and 3
tables and/or figures.
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Concepts: Descriptions of clinical and nonclinical problems and solutions; descriptions of novel
approaches to planning, management, or provision of emergency services; and practical "how-to"
articles describing aspects of emergency medicine management. A narrative abstract is required.
Maximum length: 3,000 words, plus the abstract (max 300 words) and references (max 50).
Review Articles (commissioned): Extensive reviews of the literature on a narrow clinical topic.
References must include, but need not be limited to, the past 3 years of the literature. A narrative
abstract is required. Do not combine a case report with a literature review. Maximum length: 3,000
words, plus the narrative abstract (max 300 words) and references (max 50).
Case Conferences (commissioned): Presentation and discussion of a case by an expert, focused on the
problem-solving approach toward a particular clinical problem and discussion of differential diagnoses
and subsequent management at various stages of the patient's evaluation. Maximum length: 3,000
words plus the abstract (max 300 words) and references (max 50).
Case Reports: Brief descriptions of a previously undocumented disease process, a unique unreported
manifestation or treatment of a known disease process, or unique unreported complications of
treatment regimens. Case reports should contain an introduction, narrative, and a discussion focusing
on the implications of the case reported. They should not contain a review of the literature. Maximum
length: 1,000 words, plus abstract (max 150 words) and references (max 10), and 1 table or figure.
Editorials (commissioned): Authoritative comments or opinions on major current problems of
emergency physicians or on controversial matters with significant implications for emergency
medicine; or, qualified, thorough analysis and criticism of articles appearing in AfJEM. Maximum
length: 1,500 words plus references (max 5).
Brief Commentaries (commissioned): Brief discussion focusing on 1 or 2 key points about a single
study-strengths, weaknesses, where it fits in the context of other studies, controversies, how it should
or should not change our clinical practice, or how it illustrates some important principle of science or
methodology. Maximum length: 750 words plus references (max 5).
Correspondence: Discussion, observations, opinions, corrections, and comments on topics appearing
in AfJEM; very brief reports or other items of interest. Maximum length: 500 words, plus references
(max 5). Letters discussing an AfJEM article should be received within 6 weeks of the article's
publication. Authors of articles about which letters are received will be given the opportunity to reply,
which will not be shared with the letter writer prior to publication. Letters of political or other topics
unrelated to the science of medicine, as well as those containing personal criticisms, will not be
published.
Erratum: Corrections on topics appearing in AfJEM. Maximum length: 300 words, plus references (max
5). Authors of articles about which letters are received will be given the opportunity to reply, which will
not be shared with the letter writer prior to publication. Letters of political or other topics unrelated
to the science of medicine, as well as those containing personal criticisms, will not be published.
PREPARATION
Use of wordprocessing software
It is important that the file be saved in the native format of the wordprocessor used. The text should
be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes
will be removed and replaced on processing the article. In particular, do not use the wordprocessor's
options to justify text or to hyphenate words. However, do use bold face, italics, subscripts,
superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each
individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns.
The electronic text should be prepared in a way very similar to that of conventional manuscripts
(see also the Guide to Publishing with Elsevier: http://www.elsevier.com/guidepublication). Note that
source files of figures, tables and text graphics will be required whether or not you embed your figures
in the text. See also the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your wordprocessor.
Article structure
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Subdivision - numbered sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered
1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this
numbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be
given a brief heading. Each heading should appear on its own separate line.
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature
survey or a summary of the results.
Material and methods
Provide sufficient detail to allow the work to be reproduced. Methods already published should be
indicated by a reference: only relevant modifications should be described.
Theory/calculation
A Theory section should extend, not repeat, the background to the article already dealt with in the
Introduction and lay the foundation for further work. In contrast, a Calculation section represents a
practical development from a theoretical basis.
Results
Results should be clear and concise.
Discussion
This should explore the significance of the results of the work, not repeat them. A combined Results
and Discussion section is often appropriate. Avoid extensive citations and discussion of published
literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand
alone or form a subsection of a Discussion or Results and Discussion section.
Appendices
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in
appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix,
Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.
Essential title page information
•  Title.  Concise and informative. Titles are often used in information-retrieval systems. Avoid
abbreviations and formulae where possible.
•  Author names, affiliations and contribution.  Where the family name may be ambiguous
(e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where
the actual work was done) below the names. Indicate all affiliations with a lower-case superscript
letter immediately after the author's name and in front of the appropriate address. Provide the full
postal address of each affiliation, including the country name, and, if available, the e-mail address
of each author. The contribution of each author must also be described briefly. This should be done
in a paragraph below the names and affiliations and must reference the names of all authors. This
is discussed under the heading authorship above.
•  Conflict of interest statement.   Conflict of interest exists when a participant in the publication
process has a competing interest that could unduly influence (or be reasonably seen to do so) his or
her involvement in the publication process. Authors are expected to make a clear statement of any
competing interests. Examples are discussed under the heading Conflict of interest above.
•  Corresponding author.  Clearly indicate who will handle correspondence at all stages of refereeing
and publication, also post-publication. Ensure that telephone and fax numbers (with country
and area code) are provided in addition to the e-mail address and the complete postal
address. Contact details must be kept up to date by the corresponding author.
•  Present/permanent address.  If an author has moved since the work described in the article
was done, or was visiting at the time, a "Present address" (or "Permanent address") may be indicated
as a footnote to that author's name. The address at which the author actually did the work must be
retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
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Abstract
A concise and factual abstract of no more than 300 words is required. The abstract should state briefly
the purpose of the research, the principal results and major conclusions. An abstract is often presented
separately from the article, so it must be able to stand alone. A maximum of three references can
be used. Non-standard or uncommon abbreviations should be avoided, but if essential, it must be
defined at the first mention.
Types of abstracts include:
•Research abstracts should adhere to the following format: Introduction, Methods, Results and
Conclusion.
•Case reports should contain an introduction, narrative and a discussion focusing on the implications
of the case reported.
•Other narrative abstracts are acceptable for non-research abstracts (opinions, concepts and
commentary).
Graphical abstract
A Graphical abstract is optional and would only be required on request from the editor. It
should summarize the contents of the article in a concise, pictorial form designed to capture the
attention of a wide readership online. Authors must provide images that clearly represent the
work described in the article. Graphical abstracts should be submitted as a separate file in the
online submission system. Image size: Please provide an image with a minimum of 531 × 1328
pixels (h × w) or proportionally more. Preferred file types: TIFF, EPS, PDF or MS Office files. See
http://www.elsevier.com/graphicalabstracts for examples.
Highlights
Highlights are a short collection of bullet points that convey the core findings of the article. Highlights
should be submitted in a separate file in the online submission system. Please use 'Highlights' in the
file name and include 3 to 5 bullet points (maximum 85 characters per bullet point including spaces).
See http://www.elsevier.com/highlights for examples.
African relevance
African relevance is a short collection of bullet points that convey the relevance of the article in the
African context. African relevance should be submitted in a separate file in the online submission
system. Please use 'African relevance' in the file name and include 3 to 5 bullet points (maximum 85
characters per bullet point including spaces).
Keywords
Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and
avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing
with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords
will be used for indexing purposes.
Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the first page
of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first
mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article.
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those
individuals who provided help during the research (e.g., providing language help, writing assistance
or proof reading the article, etc.).
Math formulae
Present simple formulae in the line of normal text where possible and use the solidus (/) instead of
a horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in
italics. Powers of e are often more conveniently denoted by exp. Number consecutively any equations
that have to be displayed separately from the text (if referred to explicitly in the text).
Footnotes
Footnotes should be used sparingly. Number them consecutively throughout the article, using
superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature may
be used. Should this not be the case, indicate the position of footnotes in the text and present the
footnotes themselves separately at the end of the article. Do not include footnotes in the Reference
list.
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Table footnotes
Indicate each footnote in a table with a superscript lowercase letter.
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is finalised, please "save as" or
convert the images to one of the following formats (note the resolution requirements for line drawings,
halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text as "graphics".
TIFF: colour or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (colour or grayscale): a minimum of 500 dpi is required.
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then
please supply "as is".
Please do not:
• Supply files that are optimised for screen use (like GIF, BMP, PICT, and WPG); the resolution is
too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Colour artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with
the correct resolution. If, together with your accepted article, you submit usable colour figures then
Elsevier will ensure, at no additional charge, that these figures will appear in colour on the Web (e.g.,
ScienceDirect and other sites) in addition to colour reproduction in print. For further information on
the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables
below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be
sparing in the use of tables and ensure that the data presented in tables do not duplicate results
described elsewhere in the article.
References
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice
versa). Any references cited in the abstract must be given in full. Unpublished results and personal
communications are not recommended in the reference list, but may be mentioned in the text. If these
references are included in the reference list they should follow the standard reference style of the
journal and should include a substitution of the publication date with either 'Unpublished results' or
'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted
for publication.
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Web references
As a minimum, the full URL should be given and the date when the reference was last accessed. Any
further information, if known (DOI, author names, dates, reference to a source publication, etc.),
should also be given. Web references can be listed separately (e.g., after the reference list) under a
different heading if desired, or can be included in the reference list.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in
the text) to other articles in the same Special Issue.
Reference style
Text: Indicate references by superscript numbers in the text. The actual authors can be referred to,
but the reference number(s) must always be given.
List: Number the references in the list in the order in which they appear in the text.
Examples:
Reference to a journal publication:
1. Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun
2000;163:51–9.
Reference to a book:
2. Strunk Jr W, White EB. The elements of style. 3rd ed. New York: Macmillan; 1979.
Reference to a chapter in an edited book:
3. Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith
RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 1999, p. 281–304.
Note shortened form for last page number. e.g., 51–9, and that for more than 6 authors the first 6
should be listed followed by "et al." For further details you are referred to "Uniform Requirements
for Manuscripts submitted to Biomedical Journals" (J Am Med Assoc 1997;277:927–934) (see also
http://www.nlm.nih.gov/bsd/uniform_requirements.html).
Journal abbreviations source
Journal names should be abbreviated according to
Index Medicus journal abbreviations: http://www.nlm.nih.gov/tsd/serials/lji.html;
List of title word abbreviations: http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service): http://www.cas.org/sent.html.
Video data
Elsevier accepts video material and animation sequences to support and enhance your scientific
research. Authors who have video or animation files that they wish to submit with their article are
strongly encouraged to include these within the body of the article. This can be done in the same way
as a figure or table by referring to the video or animation content and noting in the body text where it
should be placed. All submitted files should be properly labelled so that they directly relate to the video
file's content. In order to ensure that your video or animation material is directly usable, please provide
the files in one of our recommended file formats with a preferred maximum size of 50 MB. Video and
animation files supplied will be published online in the electronic version of your article in Elsevier
Web products, including ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' with your
files: you can choose any frame from the video or animation or make a separate image. These will
be used instead of standard icons and will personalize the link to your video data. For more detailed
instructions please visit our video instruction pages at http://www.elsevier.com/artworkinstructions.
Note: since video and animation cannot be embedded in the print version of the journal, please
provide text for both the electronic and the print version for the portions of the article that refer to
this content.
Supplementary data
Elsevier accepts electronic supplementary material to support and enhance your scientific research.
Supplementary files offer the author additional possibilities to publish supporting applications, high-
resolution images, background datasets, sound clips and more. Supplementary files supplied will be
published online alongside the electronic version of your article in Elsevier Web products, including
ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is
directly usable, please provide the data in one of our recommended file formats. Authors should
submit the material in electronic format together with the article and supply a concise and descriptive
caption for each file. For more detailed instructions please visit our artwork instruction pages at
http://www.elsevier.com/artworkinstructions.
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Submission checklist
The following list will be useful during the final checking of an article prior to sending it to the journal
for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One Author designated as corresponding Author:
• E-mail address
• Full postal address
• Telephone and fax numbers
All necessary files have been uploaded including:
• Highlights (uploaded as separate document)
• African relevance (uploaded as separate document)
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Author affiliations and contribution to manuscript described
• Conflict of interest statements
• Manuscript has been "spellchecked" and "grammar-checked"
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
• Colour figures are clearly marked as being intended for colour reproduction on the Web (free of
charge) and in print or to be reproduced in colour on the Web (free of charge) and in black-and-
white in print
• If only colour on the Web is required, black and white versions of the figures are also supplied for
printing purposes
For any further information please visit our customer support site at http://support.elsevier.com.
AFTER ACCEPTANCE
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI
consists of a unique alpha-numeric character string which is assigned to a document by the publisher
upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal
medium for citing a document, particularly 'Articles in press' because they have not yet received their
full bibliographic information. The correct format for citing a DOI is shown as follows (example taken
from a document in the journal Physics Letters B):
doi:10.1016/j.physletb.2010.09.059
When you use the DOI to create URL hyperlinks to documents on the web, the DOIs are guaranteed
never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in
the e-mail so that authors can download the files themselves. Elsevier now provides authors with
PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 (or
higher) available free from http://get.adobe.com/reader. Instructions on how to annotate PDF files
will accompany the proofs (also given online). The exact system requirements are given at the Adobe
site: http://www.adobe.com/products/reader/tech-specs.html.
If you do not wish to use the PDF annotations function, you may list the corrections (including
replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections
quoting line number. If, for any reason, this is not possible, then mark the corrections and any other
comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan
the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing,
completeness and correctness of the text, tables and figures. Significant changes to the article as
accepted for publication will only be considered at this stage with permission from the Editor. We will
do everything possible to get your article published quickly and accurately – please let us have all your
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corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one
communication: please check carefully before replying, as inclusion of any subsequent corrections
cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with
the publication of your article if no response is received.
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For an
extra charge, paper offprints can be ordered via the offprint order form which is sent once the article
is accepted for publication. The PDF file is a watermarked version of the published article and includes
a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.
AUTHOR INQUIRIES
For inquiries relating to the submission of articles (including electronic submission) please
visit this journal's homepage. Contact details for questions arising after acceptance of
an article, especially those relating to proofs, will be provided by the publisher. You
can track accepted articles at http://www.elsevier.com/trackarticle. You can also check
our Author FAQs (http://www.elsevier.com/authorFAQ) and/or contact Customer Support via
http://support.elsevier.com.
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